Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Jun. 28, 2015 | Aug. 05, 2015 | Dec. 28, 2014 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Jun. 28, 2015 | ||
Document Fiscal Year Focus | 2,015 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | LRCX | ||
Entity Registrant Name | LAM RESEARCH CORP | ||
Entity Central Index Key | 707,549 | ||
Current Fiscal Year End Date | --06-28 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Common Stock, Shares Outstanding | 158,186,976 | ||
Entity Public Float | $ 8,838,403,605 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Revenue | $ 5,259,312 | $ 4,607,309 | $ 3,598,916 |
Cost of goods sold | 2,974,976 | 2,599,828 | 2,195,857 |
Gross margin | 2,284,336 | 2,007,481 | 1,403,059 |
Research and development | 825,242 | 716,471 | 683,688 |
Selling, general and administrative | 591,611 | 613,341 | 601,300 |
Goodwill impairment | 79,444 | 0 | 0 |
Total operating expenses | 1,496,297 | 1,329,812 | 1,284,988 |
Operating income | 788,039 | 677,669 | 118,071 |
Gain on sale of real estate | 83,090 | ||
Other expense, net | (47,189) | (37,396) | (51,413) |
Income before income taxes | 740,850 | 723,363 | 66,658 |
Income tax (expense) benefit | (85,273) | (91,074) | 47,221 |
Net income | $ 655,577 | $ 632,289 | $ 113,879 |
Net income per share: | |||
Basic | $ 4.11 | $ 3.84 | $ 0.67 |
Diluted | $ 3.70 | $ 3.62 | $ 0.66 |
Number of shares used in per share calculations: | |||
Basic | 159,629 | 164,741 | 168,932 |
Diluted | 177,067 | 174,503 | 173,430 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Net income | $ 655,577 | $ 632,289 | $ 113,879 |
Other comprehensive income (loss), net of tax: | |||
Foreign currency translation adjustment | (22,139) | 4,192 | 5,303 |
Cash flow hedges: | |||
Net unrealized gains during the period | 1,595 | 8,004 | 10,607 |
Net gains reclassified into earnings | (4,388) | (10,892) | (7,573) |
Net change | (2,793) | (2,888) | 3,034 |
Available-for-sale investments: | |||
Net unrealized gains (losses) during the period | (5,389) | 1,407 | (3,844) |
Net losses reclassified into earnings | 71 | 165 | 4,137 |
Net change | (5,318) | 1,572 | 293 |
Defined benefit plans, net change in unrealized component | 1,109 | (2,838) | (3,505) |
Other comprehensive income (loss), net of tax | (29,141) | 38 | 5,125 |
Comprehensive income | $ 626,436 | $ 632,327 | $ 119,004 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
ASSETS | ||
Cash and cash equivalents | $ 1,501,539 | $ 1,452,677 |
Short-term investments | 2,574,947 | 1,612,967 |
Accounts receivable, less allowance for doubtful accounts of $4,890 as of June 28, 2015 and $4,962 as of June 29, 2014 | 1,093,582 | 800,616 |
Inventories | 943,346 | 740,503 |
Prepaid expenses and other current assets | 157,435 | 176,899 |
Total current assets | 6,270,849 | 4,783,662 |
Property and equipment, net | 621,418 | 543,496 |
Restricted cash and investments | 170,969 | 146,492 |
Goodwill | 1,387,509 | 1,466,225 |
Intangible assets, net | 728,140 | 894,078 |
Other assets | 185,763 | 159,353 |
Total assets | 9,364,648 | 7,993,306 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||
Trade accounts payable | 300,203 | 223,515 |
Accrued expenses and other current liabilities | 649,438 | 604,296 |
Deferred profit | 322,070 | 235,923 |
Current portion of convertible notes and capital leases | 1,359,650 | 518,267 |
Total current liabilities | 2,631,361 | 1,582,001 |
Senior notes, convertible notes, and capital leases, less current portion | 1,001,382 | 817,202 |
Income taxes payable | 202,930 | 258,357 |
Other long-term liabilities | 184,023 | 122,662 |
Total liabilities | $ 4,019,696 | $ 2,780,222 |
Commitments and contingencies | ||
Temporary equity, convertible notes | $ 241,808 | $ 183,349 |
Stockholders' equity: | ||
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding | ||
Common stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding - 158,531 shares at June 28, 2015 and 162,350 shares at June 29, 2014 | $ 159 | $ 162 |
Additional paid-in capital | 5,366,773 | 5,239,567 |
Treasury stock, at cost, 99,562 shares at June 28, 2015 and 92,867 shares at June 24, 2014 | (4,302,847) | (3,757,076) |
Accumulated other comprehensive loss | (57,796) | (28,655) |
Retained earnings | 4,096,855 | 3,575,737 |
Total stockholders' equity | 5,103,144 | 5,029,735 |
Total liabilities and stockholders' equity | $ 9,364,648 | $ 7,993,306 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Accounts receivable, allowance for doubtful accounts | $ 4,890 | $ 4,962 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 400,000,000 | 400,000,000 |
Common stock, shares issued | 158,531,000 | 162,350,000 |
Common stock, shares outstanding | 158,531,000 | 162,350,000 |
Treasury stock, shares | 99,562,000 | 92,867,000 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |||
Net income | $ 655,577 | $ 632,289 | $ 113,879 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 277,920 | 292,254 | 304,116 |
Deferred income taxes | 5,551 | 7,537 | (70,155) |
Impairment of long-lived assets | 9,821 | 11,632 | |
Impairment of investment | 3,711 | ||
Equity-based compensation expense | 135,354 | 103,700 | 99,330 |
Income tax benefit (expense) on equity-based compensation plans | 11,316 | 5,973 | (483) |
Excess tax (benefit) expense on equity-based compensation plans | (11,398) | (6,065) | 539 |
Amortization of note discounts and issuance costs | 37,550 | 35,482 | 33,920 |
Gain on sale of business | (7,431) | ||
Gain on sale of real estate | (83,090) | ||
Goodwill impairment | 79,444 | 0 | 0 |
Other, net | 12,656 | 12,669 | 37,201 |
Changes in operating asset and liability accounts: | |||
Accounts receivable, net of allowance | (294,155) | (201,549) | 162,634 |
Inventories | (207,462) | (190,058) | 76,351 |
Prepaid expenses and other assets | (52,496) | (11,923) | 518 |
Trade accounts payable | 76,617 | 18,704 | (58,081) |
Deferred profit | 86,146 | 10,886 | 60,205 |
Accrued expenses and other liabilities | (29,507) | 78,608 | (43,752) |
Net cash provided by operating activities | 785,503 | 717,049 | 719,933 |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||
Capital expenditures and intangible assets | (198,265) | (145,503) | (160,795) |
Business acquisitions, net of cash acquired | (1,137) | (30,227) | (9,916) |
Purchases of available-for-sale securities | (3,086,808) | (1,312,244) | (1,097,956) |
Sales and maturities of available-for-sale securities | 2,137,068 | 1,028,278 | 1,039,551 |
Purchase of other investments | (2,500) | ||
Issuance (repayment) of notes receivable | 3,978 | 10,000 | (10,000) |
Proceeds from sale of assets | 156,397 | 660 | |
Proceeds from sale of business | 41,212 | ||
Transfer of restricted cash and investments | 356 | 28,085 | (181) |
Net cash used for investing activities | (1,106,096) | (265,214) | (238,637) |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||
Principal payments on long-term debt and capital lease obligations | (1,515) | (1,658) | (2,234) |
Net proceeds from issuance of long-term debt | 992,225 | ||
Excess tax benefit (expense) on equity-based compensation plans | 11,398 | 6,065 | (539) |
Treasury stock purchases | (573,240) | (244,859) | (955,661) |
Dividends paid | (116,059) | ||
Reissuances of treasury stock related to employee stock purchase plan | 48,803 | 42,926 | 31,265 |
Proceeds from issuance of common stock | 17,520 | 34,791 | 39,379 |
Other | (660) | ||
Net cash provided by (used for) financing activities | 378,472 | (162,735) | (887,790) |
Effect of exchange rate changes on cash and cash equivalents | (9,017) | 1,104 | 4,215 |
Net increase (decrease) in cash and cash equivalents | 48,862 | 290,204 | (402,279) |
Cash and cash equivalents at beginning of year | 1,452,677 | 1,162,473 | 1,564,752 |
Cash and cash equivalents at end of year | 1,501,539 | 1,452,677 | 1,162,473 |
Schedule of noncash transactions | |||
Accrued payables for stock repurchases | 3,255 | 3,392 | |
Supplemental disclosures: | |||
Cash payments for interest | 26,393 | 26,489 | 26,635 |
Cash payments for income taxes, net | $ 114,512 | $ 18,157 | $ 7,695 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Treasury Stock | Accumulated Other Comprehensive Income (Loss) | Retained Earnings |
Beginning Balance (in shares) at Jun. 30, 2012 | 186,656 | |||||
Beginning Balance at Jun. 30, 2012 | $ 5,131,781 | $ 187 | $ 4,943,539 | $ (2,636,936) | $ (33,818) | $ 2,858,809 |
Sale of common stock (in shares) | 3,301 | |||||
Sale of common stock | 39,380 | $ 3 | 39,377 | |||
Purchase of treasury stock (in shares) | (28,157) | |||||
Purchase of treasury stock | (934,808) | $ (28) | (934,780) | |||
Income tax benefits on equity-based compensation plans | (483) | (483) | ||||
Reissuance of treasury stock (in shares) | 1,073 | |||||
Reissuance of treasury stock | 31,265 | $ 1 | (622) | 31,886 | ||
Equity-based compensation expense | 99,310 | 99,310 | ||||
Reclassification from temporary to permanent equity | 3,423 | 3,423 | ||||
Net income | 113,879 | 113,879 | ||||
Other comprehensive income | 5,125 | 5,125 | ||||
Ending Balance (in shares) at Jun. 30, 2013 | 162,873 | |||||
Ending Balance at Jun. 30, 2013 | 4,488,872 | $ 163 | 5,084,544 | (3,539,830) | (28,693) | 2,972,688 |
Sale of common stock (in shares) | 3,140 | |||||
Sale of common stock | 34,791 | $ 3 | 34,788 | |||
Purchase of treasury stock (in shares) | (4,860) | |||||
Purchase of treasury stock | (253,185) | $ (5) | (253,180) | |||
Income tax benefits on equity-based compensation plans | 5,973 | 5,973 | ||||
Reissuance of treasury stock (in shares) | 1,197 | |||||
Reissuance of treasury stock | 42,926 | $ 1 | 6,991 | 35,934 | ||
Equity-based compensation expense | 103,700 | 103,700 | ||||
Reclassification from temporary to permanent equity | 3,571 | 3,571 | ||||
Net income | 632,289 | 632,289 | ||||
Other comprehensive income | 38 | 38 | ||||
Cash dividends declared (For 2014 $.18 and for 2015 $.84 per per common share) | (29,240) | (29,240) | ||||
Ending Balance (in shares) at Jun. 29, 2014 | 162,350 | |||||
Ending Balance at Jun. 29, 2014 | 5,029,735 | $ 162 | 5,239,567 | (3,757,076) | (28,655) | 3,575,737 |
Sale of common stock (in shares) | 2,876 | |||||
Sale of common stock | 17,523 | $ 4 | 17,519 | |||
Purchase of treasury stock (in shares) | (7,638) | |||||
Purchase of treasury stock | (573,104) | $ (8) | (573,096) | |||
Income tax benefits on equity-based compensation plans | 11,316 | 11,316 | ||||
Reissuance of treasury stock (in shares) | 943 | |||||
Reissuance of treasury stock | 48,803 | $ 1 | 21,477 | 27,325 | ||
Equity-based compensation expense | 135,354 | 135,354 | ||||
Reclassification from temporary to permanent equity | (58,460) | (58,460) | ||||
Net income | 655,577 | 655,577 | ||||
Other comprehensive income | (29,141) | (29,141) | ||||
Cash dividends declared (For 2014 $.18 and for 2015 $.84 per per common share) | (134,459) | (134,459) | ||||
Ending Balance (in shares) at Jun. 28, 2015 | 158,531 | |||||
Ending Balance at Jun. 28, 2015 | $ 5,103,144 | $ 159 | $ 5,366,773 | $ (4,302,847) | $ (57,796) | $ 4,096,855 |
Consolidated Statements of Sto8
Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares | 12 Months Ended | |
Jun. 28, 2015 | Jun. 29, 2014 | |
Dividend Per share | $ 0.84 | $ 0.18 |
Company and Industry Informatio
Company and Industry Information | 12 Months Ended |
Jun. 28, 2015 | |
Company and Industry Information | Note 1: Company and Industry Information The Company designs, manufactures, markets, refurbishes and services semiconductor processing equipment used in the fabrication of integrated circuits. Semiconductor wafers are subjected to a complex series of process and preparation steps that result in the simultaneous creation of many individual integrated circuits. The Company leverages its expertise in the areas of deposition, etch, and single-wafer clean to develop processing solutions that are designed to benefit its customers through lower defect rates, enhanced yields, faster processing time, and/or reduced cost. The Company sells its products and services primarily to companies involved in the production of semiconductors in United States, Europe, Taiwan, Korea, Japan, China, and Southeast Asia. The semiconductor industry is cyclical in nature and has historically experienced periodic downturns and upturns. Today’s leading indicators of changes in customer investment patterns, such as electronics demand, memory pricing, and foundry utilization rates, may not be any more reliable than in prior years. Demand for the Company’s equipment can vary significantly from period to period as a result of various factors, including, but not limited to, economic conditions, supply, demand, and prices for semiconductors, customer capacity requirements, and the Company’s ability to develop and market competitive products. For these and other reasons, the Company’s results of operations for fiscal years 2015, 2014, and 2013 may not necessarily be indicative of future operating results. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Jun. 28, 2015 | |
Summary of Significant Accounting Policies | Note 2: Summary of Significant Accounting Policies The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), requires management to make judgments, estimates, and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience and on various other assumptions it believes to be applicable, and evaluates them on an on-going basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates. Revenue Recognition: Inventory Valuation: Management evaluates the need to record adjustments for impairment of inventory at least quarterly. The Company’s policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of goods sold in the period in which the revision is made. Warranty: While the Company periodically monitors the performance and cost of warranty activities, if actual costs incurred are different than its estimates, the Company may recognize adjustments to provisions in the period in which those differences arise or are identified. In addition to the provision of standard warranties, the Company offers customer-paid extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded as incurred. Equity-based Compensation — Employee Stock Purchase Plan (“ESPP”) and Employee Stock Plans: The Company makes quarterly assessments of the adequacy of its tax credit pool related to equity-based compensation to determine if there are any deficiencies that it is required to recognize in the Company’s Condensed Consolidated Statements of Operations. The Company will only recognize a benefit from equity-based compensation in paid-in-capital if it realizes an incremental tax benefit after all other tax attributes currently available to us have been utilized. In addition, the Company has elected to account for the indirect benefits of equity-based compensation on the research tax credit through the income statement rather than through paid-in-capital. The Company also elected to net deferred tax assets and the associated valuation allowance related to net operating loss and tax credit carryforwards for the accumulated stock award tax benefits for income tax footnote disclosure purposes. The Company tracks these stock award attributes separately and will only recognize these attributes through paid-in-capital. Income Taxes: The Company recognizes the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. The Company’s policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense. Goodwill and Intangible Assets: Goodwill represents the amount by which the purchase price in each business combination exceeds the fair value of the net tangible and identifiable intangible assets acquired. Each component of the Company for which discrete financial information is available and for which management regularly reviews the results of operations is considered a reporting unit. All goodwill acquired in a business combination is assigned to one or more reporting units as of the acquisition date. Goodwill is assigned to the Company’s reporting units that are expected to benefit from the synergies of the combination. The goodwill assigned to a reporting unit is the difference between the acquisition consideration assigned to the reporting unit on a relative fair value basis and the fair value of acquired assets and liabilities that can be specifically attributed to the reporting unit. The Company tests goodwill and identifiable intangible assets with indefinite useful lives for impairment at least annually. The Company amortizes intangible assets with estimable useful lives over their respective estimated useful lives, and the Company reviews for impairment whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable and the carrying amount exceeds its fair value. The Company reviews goodwill at least annually for impairment. If certain events or indicators of impairment occur between annual impairment tests, the Company would perform an impairment test at that date. In testing for a potential impairment of goodwill, the Company: (1) allocates goodwill to its reporting units to which the acquired goodwill relates; (2) estimates the fair value of its reporting units; and (3) determines the carrying value (book value) of those reporting units. Furthermore, if the estimated fair value of a reporting unit is less than the carrying value, the Company must estimate the fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require independent valuations of certain internally generated and unrecognized intangible assets such as in-process R&D and developed technology. Only after this process is completed can the amount of goodwill impairment, if any, be determined. In the Company’s goodwill impairment process it first assesses qualitative factors to determine whether it is necessary to perform a quantitative analysis. The Company does not calculate the fair value of a reporting unit unless the Company determines, based on a qualitative assessment, that it is more-likely-than-not that its fair value is less than its carrying amount. The Company performed the most recent annual goodwill impairment analysis as of the first day of its fourth quarter of fiscal year 2015, March 30, 2015, resulted in an impairment charge on the Company’s single-wafer clean reporting unit of approximately $79.4 million. The Company did not record any goodwill impairment in fiscal years 2014 or 2013. The process of evaluating the potential impairment of goodwill is subjective and requires significant judgment at many points during the analysis. The Company determines the fair value of its reporting units by using an income approach. Under the income approach, the Company determines fair value based on estimated future cash flows of each reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit and the rate of return an outside investor would expect to earn. In estimating the fair value of a reporting unit, the Company makes estimates and judgments about the future cash flows of its reporting units, including estimated growth rates and assumptions about the economic environment. Although the Company’s cash flow forecasts are based on assumptions that are consistent with the plans and estimates it is using to manage the underlying businesses, there is significant judgment involved in determining the cash flows attributable to a reporting unit. In addition, the Company makes certain judgments about allocating shared assets to the estimated balance sheets of its reporting units. Changes in judgment on these assumptions and estimates could result in a goodwill impairment charge. As a result, several factors could result in impairment of a material amount of the Company’s goodwill balance in future periods, including, but not limited to: (1) weakening of the global economy, weakness in the semiconductor equipment industry, or failure of the Company to reach its internal forecasts, which could impact the Company’s ability to achieve its forecasted levels of cash flows and reduce the estimated discounted cash flow value of its reporting units; and (2) a decline in the Company’s stock price and resulting market capitalization, and to the extent the Company determines that the decline is sustained and indicates a reduction in the fair value of the Company’s reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, is based on estimates and judgments regarding expectations such as the success and life cycle of products and technology acquired. If actual product acceptance differs significantly from the estimates, the Company may be required to record an impairment charge to write down the asset to its realizable value. The Company reviews indefinite-lived intangible assets for an impairment annually, or when events or circumstances indicate the carrying value may not be recoverable. Factors that may be a change in circumstances, indicating the carrying value of amortizable intangible assets may not be recoverable, include a reduced future cash flow estimate, and slower growth rates in the industry segment in which the Company participates. The Company determines whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying value. If the sum is less, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. The Company recognizes an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The Company recognized a $4.0 million impairment charge related to indefinite-lived intangible asset during the year ended June 29, 2014. The Company did not record an impairment charge on indefinite-lived intangible assets during the years ended June 28, 2015 or June 30, 2013. Impairment of Long-Lived Assets (Excluding Goodwill and indefinite-lived Intangibles): Fiscal Year: Principles of Consolidation: Cash Equivalents and Short-Term Investments: Allowance for Doubtful Accounts: Property and Equipment: Derivative Financial Instruments: To hedge foreign currency risks, the Company uses foreign currency exchange forward contracts, where possible and prudent. These forward contracts are valued using standard valuation formulas with assumptions about future foreign currency exchange rates derived from existing exchange rates, interest rates, and other market factors. The Company considers its most current forecast in determining the level of foreign currency denominated revenue and expenses to hedge as cash flow hedges. The Company combines these forecasts with historical trends to establish the portion of its expected volume to be hedged. The revenue and expenses are hedged and designated as cash flow hedges to protect the Company from exposures to fluctuations in foreign currency exchange rates. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge gains and losses on the cash flow hedge are reclassified from accumulated other comprehensive income (loss) to other income (expense), net on the consolidated statement of operations at that time. Guarantees: Foreign Currency Translation: |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 12 Months Ended |
Jun. 28, 2015 | |
Recent Accounting Pronouncements | Note 3: Recent Accounting Pronouncements In July 2013, the FASB released Accounting Standards Update 2013-11 “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” The new standard requires that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset for a net operating loss carryforward or other tax credit carryforward when settlement in this manner is available under the tax law. The Company adopted this standard during the fiscal year without significant impact on its financial position, results of operations, or cash flows. In April 2014, the FASB released Accounting Standards Update 2014-8 “Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.” The new standard re-defines discontinued operations and requires only those disposals of components of an entity, including classifications as held for sale, that represent a strategic shift that has, or will have, a major effect on an entity’s operations and financial results to be reported as discontinued operations. In addition, the new standard expands the disclosure requirements of discontinued operations. The Company adopted this standard during the fiscal year without significant impact on its financial position, results of operations, or cash flows. In May 2014, the FASB released Accounting Standards Update 2014-9 “Revenue from Contracts with Customers” to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method, and is in the process of determining the impact that the new standard will have on its Consolidated Financial Statements. In April 2015, the FASB released Accounting Standards Update 2015-3 “Interest — Imputation of Interest.” The amendment requires that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company is required to adopt this standard starting in the first quarter of fiscal year 2017, and does not anticipate the adoption will have a material impact on its Consolidated Financial Statements. |
Reclassifications
Reclassifications | 12 Months Ended |
Jun. 28, 2015 | |
Reclassifications | Note 4: Reclassifications Certain amounts in fiscal years 2014 and 2013 financial statements have been reclassified to conform to the fiscal year 2015 presentation. |
Equity-Based Compensation Plans
Equity-Based Compensation Plans | 12 Months Ended |
Jun. 28, 2015 | |
Equity-Based Compensation Plans | Note 5: Equity-Based Compensation Plans The Company has stock plans that provide for grants of equity-based awards to eligible participants, including stock options and restricted stock units (“RSUs”), of Lam Research common stock (“Common Stock”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s options and RSU awards typically vest over a period of three years or less, although awards assumed in connection with the acquisition of Novellus Systems, Inc. (“Novellus”), have vesting terms up to four years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions. The Company recognized the following equity-based compensation expense and benefits in the Condensed Consolidated Statements of Operations: Year Ended June 28, June 29, June 30, (in thousands) Equity-based compensation expense $ 135,354 $ 103,700 $ 99,310 Income tax benefit recognized in the related to equity-based compensation $ 23,660 $ 16,937 $ 17,647 Income tax benefit realized from the exercise and vesting of options and RSUs $ 40,401 $ 31,993 $ 21,625 The estimated fair value of the Company’s equity-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis. Stock Options and RSUs The Lam Research Corporation 2007 Stock Incentive Plan, as amended and restated, and 2011 Stock Incentive Plan, as amended and restated (collectively the “Stock Plans”), provide for the grant of non-qualified equity-based awards to eligible employees, consultants and advisors, and non-employee directors of the Company and its subsidiaries. A summary of stock plan transactions is as follows: Options Outstanding Restricted Stock Units Outstanding Number of Weighted-Average Price Number of Weighted-Average June 24, 2012 3,902,077 $ 25.14 4,331,478 $ 41.01 Granted 288,867 $ 42.59 2,563,670 $ 38.76 Exercised (1,546,028 ) $ 25.47 N/A N/A Canceled (73,993 ) $ 26.24 (299,079 ) $ 39.70 Vested restricted stock N/A N/A (1,754,273 ) $ 42.52 June 30, 2013 2,570,923 $ 26.87 4,841,796 $ 39.32 Granted 166,455 $ 51.76 2,811,602 $ 53.21 Exercised (1,403,019 ) $ 24.75 N/A N/A Canceled (2,473 ) $ 30.21 (281,476 ) $ 41.16 Vested restricted stock N/A N/A (1,736,453 ) $ 40.39 June 29, 2014 1,331,886 $ 32.20 5,635,469 $ 45.83 Granted 76,659 $ 80.60 1,804,937 $ 79.74 Exercised (564,558 ) $ 31.05 N/A N/A Cancelled (8,155 ) $ 29.32 (174,879 ) $ 50.16 Vested restricted stock N/A N/A (2,311,439 ) $ 41.17 June 28, 2015 835,832 $ 37.44 4,954,088 $ 60.13 Outstanding and exercisable options presented by price range at June 28, 2015 were as follows: Options Outstanding Options Exercisable Range of Exercise Prices Number of Weighted-Average Weighted-Average Number of Weighted-Average $9.44-$19.05 130,682 0.52 $ 12.94 130,682 $ 12.94 $21.04-$25.60 89,907 0.30 $ 22.13 86,845 $ 22.08 $26.87-$29.68 193,978 0.86 $ 29.26 190,025 $ 29.32 $31.45-$35.68 30,042 0.21 $ 32.94 30,042 $ 32.94 $42.41-$80.60 391,223 2.53 $ 53.54 185,101 $ 43.58 $9.44-$51.76 835,832 4.42 $ 37.44 622,695 $ 29.29 As of June 28, 2015, there were a total of 5,789,920 shares subject to options and RSUs issued and outstanding under the Company’s Stock Plans. As of June 28, 2015, there were a total of 6,572,350 shares available for future issuance under the Stock Plans. Stock Options The fair value of the Company’s stock options granted during fiscal years 2015, 2014, and 2013, was estimated using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award: Year Ended June 28, June 29, June 30, Expected volatility 34.45% 35.28% 36.60% Risk-free interest rate 1.46% 1.39% 0.81% Expected term (years) 4.80 4.78 4.79 Dividend yield 0.89% — — The year-end intrinsic value relating to stock options for fiscal years 2015, 2014, and 2013 is presented below: Year Ended June 28, June 29, June 30, (in thousands) Intrinsic value - options outstanding $ 37,961 $ 46,283 $ 44,919 Intrinsic value - options exercisable $ 33,360 $ 31,653 $ 36,870 Intrinsic value - options exercised $ 26,806 $ 41,379 $ 25,430 As of June 28, 2015, there was $2.9 million of total unrecognized compensation expense related to unvested stock options granted and outstanding; that expense is expected to be recognized over a weighted-average remaining vesting period of 2.1 years. Restricted Stock Units The fair value of the Company’s RSUs was calculated based upon the fair market value of the Company’s stock at the date of grant, discounted for dividends. As of June 28, 2015, there was $197.6 million of total unrecognized compensation expense related to all unvested RSUs granted; that expense is expected to be recognized over a weighted-average remaining vesting period of 2.1 years. During the fiscal years 2015 and 2014, the Company issued certain RSUs with both a market condition and a service condition (market-based performance RSUs, or “market-based PRSUs”). Based upon the terms of such awards, the number of shares that can be earned over the performance periods is based on the Company’s Common Stock price performance compared to the market price performance of the Philadelphia Semiconductor Sector Index (“SOX”), ranging from 0% to 150% of target. The stock price performance or market price performance is measured using the closing price for the 50-trading days prior to the dates the performance period begins and ends. The target number of shares represented by the market-based PRSUs is increased by 2% of target for each 1% that Common Stock price performance exceeds the market price performance of the SOX index. The result of the vesting formula is rounded down to the nearest whole number. Total stockholder return is a measure of stock price appreciation in this performance period. As of June 28, 2015, 0.9 million market-based PRSUs were outstanding. These market-based PRSUs generally vest two or three years from the grant date and require continued employment. Stock compensation expense for the market-based PRSUs was $13.5 million and $3.8 million for the years ended June 28, 2015 and June 29, 2014, respectively. No market-based PRSUs were awarded in earlier periods. The fair value of the Company’s market-based PRSUs granted during fiscal years 2015 and 2014, was calculated using a Monte Carlo simulation model at the date of the grant. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award: Year Ended June 28, June 29, Expected volatility 27.93% 29.27% Risk-free interest rate 1.05% 0.55% Expected term (years) 2.98 2.67 Dividend yield 0.89% — ESPP The 1999 Employee Stock Purchase Plan (the “1999 ESPP”) allows employees to designate a portion of their base compensation to be deducted and used to purchase the Company’s Common Stock at a purchase price per share of the lower of 85% of the fair market value of the Company’s Common Stock on the first or last day of the applicable purchase period. Typically, each offering period lasts 12 months and comprises three interim purchase dates. The Plan Administrator (the Compensation Committee of the Board) is authorized to set a limit on the number of shares a plan participant can purchase on any single plan exercise date. During fiscal years 2015, 2014, and 2013, there was no increase to the number of shares of Lam Research Common Stock reserved for issuance under the 1999 ESPP. During fiscal year 2015, a total of 943,055 shares of the Company’s Common Stock were sold to employees under the 1999 ESPP. At June 28, 2015, 7,434,523 shares were available for purchase under the 1999 ESPP. The 1999 ESPP rights were valued using the Black-Scholes model. During fiscal years 2015, 2014, and 2013, the 1999 ESPP was valued using the following weighted-average assumptions: Year Ended June 28, June 29, June 30, Expected term (years) 0.67 0.68 0.64 Expected stock price volatility 27.60% 30.24% 32.42% Risk-free interest rate 0.07% 0.07% 0.15% Dividend Yield 0.69% — — As of June 28, 2015, there was $2.6 million of total unrecognized compensation cost related to the 1999 ESPP that is expected to be recognized over a remaining vesting period of 2 months. |
Other Income (Expense), Net
Other Income (Expense), Net | 12 Months Ended |
Jun. 28, 2015 | |
Other Income (Expense), Net | Note 6: Other Income (Expense), Net The significant components of other income (expense), net, were as follows: Year Ended June 28, June 29, June 30, (in thousands) Interest income $ 19,268 $ 12,540 $ 14,737 Interest expense (73,682 ) (61,692 ) (60,408 ) Gains on deferred compensation plan related assets, net 9,071 9,559 9,764 Foreign exchange gains (losses), net 2,331 1,529 (6,808 ) Other, net (4,177 ) 668 (8,698 ) $ (47,189 ) $ (37,396 ) $ (51,413 ) |
Income Taxes
Income Taxes | 12 Months Ended |
Jun. 28, 2015 | |
Income Taxes | Note 7: Income Taxes The components of income (loss) before income taxes were as follows: June 28, June 29, June 30, (in thousands) United States $ 72,728 $ 78,076 $ (46,392 ) Foreign 668,122 645,287 113,050 $ 740,850 $ 723,363 $ 66,658 Significant components of the provision (benefit) for income taxes attributable to income before income taxes were as follows: June 28, June 29, June 30, (in thousands) Federal: Current $ 16,795 $ 31,762 $ (1,096 ) Deferred 12,115 10,692 (60,172 ) $ 28,910 $ 42,454 $ (61,268 ) State: Current $ 1,376 $ 3,192 $ 3,332 Deferred 158 (869 ) (6,351 ) $ 1,534 $ 2,323 $ (3,019 ) Foreign: Current $ 61,551 $ 49,273 $ 20,640 Deferred (6,722 ) (2,976 ) (3,574 ) $ 54,829 $ 46,297 $ 17,066 Total Provision (Benefit) for Income Taxes $ 85,273 $ 91,074 $ (47,221 ) Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes, and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Significant components of the Company’s net deferred tax assets and liabilities were as follows: June 28, June 29, (in thousands) Deferred tax assets: Tax carryforwards $ 129,234 $ 170,028 Allowances and reserves 131,079 126,895 Equity-based compensation 21,086 18,019 Inventory valuation differences 15,167 16,257 Other 13,942 12,661 Gross deferred tax assets 310,508 343,860 Valuation allowance (85,620 ) (74,439 ) Net deferred tax assets 224,888 269,421 Deferred tax liabilities: Intangible Assets (64,725 ) (87,329 ) Convertible debt (130,991 ) (117,112 ) Temporary differences for captial assets (37,635 ) (32,350 ) Amortization of goodwill (12,502 ) (11,409 ) Unremitted earnings of foreign subsidiaries (66,412 ) (40,286 ) Other (6,100 ) (5,673 ) Gross deferred tax liabilities (318,365 ) (294,159 ) Net deferred tax liabilities $ (93,477 ) $ (24,738 ) The change in the gross deferred tax assets, gross deferred tax liabilities and valuation allowance between fiscal year 2015 and 2014 is primarily due to the reclassification of deferred tax assets as a result of the adoption of Accounting Standards Updated 2013-11, accrual for future tax liabilities due to the expected repatriation of foreign earnings of certain foreign subsidiaries for 2015, and convertible debt accretion, offset by a decrease in deferred tax liabilities related to amortization of intangible assets. Realization of the Company’s net deferred tax assets is based upon the weighting of available evidence, including such factors as the recent earnings history and expected future taxable income. The Company believes it is more-likely-than-not that such deferred tax assets will be realized with the exception of $85.6 million primarily related to California and certain foreign deferred tax assets. The provisions related to the tax accounting for equity-based compensation prohibit the recognition of a deferred tax asset for an excess benefit that has not yet been realized. As a result, the Company will only recognize an excess benefit from equity-based compensation in additional paid-in-capital if an incremental tax benefit is realized after all other tax attributes currently available to us have been utilized. In addition, the Company continued to elect to account for the indirect benefits of equity-based compensation such as the research and development tax credit through the Consolidated Statement of Operations. At June 28, 2015, the Company had federal net operating loss carryforwards of approximately $126.3 million. The majority of these losses will begin to expire in fiscal year 2019, and are subject to limitations on their utilization. As of June 28, 2015, the Company had state net operating loss carryforwards of approximately $36.7 million. If not utilized, the net operating loss carryforwards will begin to expire in fiscal year 2016, and are subject to limitations on their utilization. At June 28, 2015, the Company had federal tax credit carryforwards of approximately $134.3 million, of which $19.2 million will begin to expire in fiscal year 2017 and $113.3 million will begin to expire in fiscal year 2030. The remaining balance of $1.8 million of credits may be carried forward indefinitely. The tax benefits relating to approximately $20.3 million of federal tax credit carryforwards will be credited to additional paid-in-capital when recognized. At June 28, 2015, the Company had state tax credit carryforwards of approximately $236.4 million. Substantially all state tax credit carryforwards may be carried forward indefinitely. At June 28, 2015, the Company had federal and state capital loss carryforwards of approximately $12.0 million, which will begin to expire in fiscal year 2020. At June 28, 2015, the Company had foreign net operating loss carryforwards of approximately $31.2 million, of which approximately $10.2 million may be carried forward indefinitely and $21.0 million will begin to expire in fiscal year 2016. A reconciliation of income tax expense provided at the federal statutory rate (35% in fiscal years 2015, 2014, and 2013) to actual income tax expense (benefit) is as follows: June 28, June 29, June 30, (in thousands) Income tax expense computed at federal statutory rate $ 259,297 $ 253,177 $ 23,332 State income taxes, net of federal tax benefit (8,611 ) 1,884 (13,588 ) Foreign income taxed at different rates (175,581 ) (164,130 ) (40,255 ) Tax credits (24,416 ) (15,650 ) (42,593 ) State valuation allowance, net of federal tax benefit 8,594 (1,707 ) 11,538 Equity-based compensation 28,845 23,167 20,318 Other permanent differences and miscellaneous items (2,855 ) (5,667 ) (5,973 ) $ 85,273 $ 91,074 $ (47,221 ) Effective from fiscal year 2014 through June 2023, the Company has a 10 year tax ruling in Switzerland for one of its foreign subsidiaries. In the prior years, the Company had a tax holiday in Switzerland which was effective from fiscal year 2003 through June 2013. The impact of the tax ruling decreased taxes by approximately $4.8 million, $7.4 million and $10.8 million for fiscal years 2015, 2014 and 2013, respectively. The benefit of the tax ruling on diluted earnings per share was approximately $0.03 in fiscal year 2015, $ 0.04 in fiscal year 2014 and $0.06 in fiscal year 2013. Unremitted earnings of the Company’s foreign subsidiaries included in consolidated retained earnings aggregated to approximately $3.3 billion at June 28, 2015. These earnings are indefinitely reinvested in foreign operations. If these earnings were remitted to the United States, they would be subject to U.S. and foreign withholding taxes of approximately $859.0 million at current statutory rates. The Company’s federal income tax provision includes U.S. income taxes on certain foreign-based income. As of June 28, 2015, the total gross unrecognized tax benefits were $363.6 million compared to $352.1 million as of June 29, 2014 and $333.1 million as of June 30, 2013. During fiscal year 2015, gross unrecognized tax benefits increased by approximately $11.4 million. The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate was $276.8 million, $269.4 million and $257.7 million, as of June 28, 2015, June 29, 2014 and June 30, 2013 respectively. The aggregate changes in the balance of gross unrecognized tax benefits were as follows: (in thousands) Balance as of June 24, 2012 $ 343,837 Settlements and effective settlements with tax authorities (3,422 ) Lapse of statute of limitations (51,422 ) Increases in balances related to tax positions taken during prior periods 11,352 Decreases in balances related to tax positions taken during prior periods (11,281 ) Increases in balances related to tax positions taken during current period 35,170 Tax positions assumed in Novellus transaction 8,880 Balance as of June 30, 2013 333,114 Lapse of statute of limitations (16,048 ) Increases in balances related to tax positions taken during prior periods 6,225 Decreases in balances related to tax positions taken during prior periods (4,182 ) Increases in balances related to tax positions taken during current period 33,003 Balance as of June 29, 2014 352,112 Settlements and effective settlements with tax authorities (2,108 ) Lapse of statute of limitations (9,376 ) Increases in balances related to tax positions taken during prior periods 3,729 Decreases in balances related to tax positions taken during prior periods (12,615 ) Increases in balances related to tax positions taken during current period 31,810 Balance as of June 28, 2015 $ 363,552 The Company recognizes interest expense and penalties related to the above unrecognized tax benefits within income tax expense. The Company had accrued $35.5 million, $29.5 million and $25.5 million cumulatively, for gross interest and penalties as of June 28, 2015, June 29, 2014 and June 30, 2013, respectively. The Company is subject to audits by state and foreign tax authorities. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the relevant taxing authorities will occur. The Company files U.S. federal, U.S. state, and foreign income tax returns. As of June 28, 2015, tax years 2004-2014 remain subject to examination in the jurisdictions where the Company operates. The Company is in various stages of the examinations in connection with all of its tax audits worldwide and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next twelve-month period the Company may experience an increase or decrease in its unrecognized tax benefits. It is not possible to determine either the magnitude or the range of any increase or decrease at this time. |
Net Income Per Share
Net Income Per Share | 12 Months Ended |
Jun. 28, 2015 | |
Net Income Per Share | Note 8: Net Income Per Share Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units (“RSUs”), and Convertible Notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Year Ended June 28, June 29, June 30, (in thousands, except per share data) Numerator: Net income $ 655,577 $ 632,289 $ 113,879 Denominator: Basic average shares outstanding 159,629 164,741 168,932 Effect of potential dilutive securities: Employee stock plans 3,193 2,864 2,558 Convertible notes 13,530 6,898 1,940 Warrants 715 — — Diluted average shares outstanding 177,067 174,503 173,430 Net income per share - basic $ 4.11 $ 3.84 $ 0.67 Net income per share - diluted $ 3.70 $ 3.62 $ 0.66 For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded: Year Ended June 28, June 29, June 30, (in thousands) Number of options and RSUs excluded 330 78 534 Diluted shares outstanding include the effect of the Convertible Notes. Diluted shares outstanding do not include any effect resulting from note hedges associated with the Company’s 2016 or 2018 Notes (as described in Note 14) as their impact would have been anti-dilutive. |
Financial Instruments
Financial Instruments | 12 Months Ended |
Jun. 28, 2015 | |
Financial Instruments | Note 9: Financial Instruments Fair Value The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions. Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by, observable market data for substantially the full term of the assets or liabilities. Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data. The Company’s primary financial instruments include cash and cash equivalents, short-term investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivatives. The estimated fair value of cash and cash equivalents, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 14 to the Consolidated Financial Statements for additional information regarding the fair value of the Company’s Convertible Notes and Senior Notes. Investments The following table sets forth the Company’s cash, cash equivalents, short-term investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of June 28, 2015 and June 29, 2014: June 28, 2015 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Short-Term Restricted Investments Other (in thousands) Cash $ 276,663 $ — $ — $ 276,663 $ 271,452 $ — $ 5,211 $ — Level 1: Time Deposit 177,567 — — 177,567 44,738 — 132,829 — Money Market Funds 1,177,875 — — 1,177,875 1,177,875 — — — US Treasury and Agencies 349,009 72 (861 ) 348,220 — 315,291 32,929 — Mutual Funds 30,584 2,926 (47 ) 33,463 — — — 33,463 Level 1 Total $ 1,735,035 $ 2,998 $ (908 ) $ 1,737,125 $ 1,222,613 $ 315,291 $ 165,758 $ 33,463 Level 2: Municipal Notes and Bonds 659,550 429 (335 ) 659,644 7,474 652,170 — — US Treasuries and Agencies 4,007 — (4 ) 4,003 — 4,003 — — Government-Sponsored Enterprises 53,612 2 (249 ) 53,365 — 53,365 — — Foreign Government Bonds 50,336 31 (161 ) 50,206 — 50,206 — — Corporate Notes and Bonds 1,329,587 685 (3,797 ) 1,326,475 — 1,326,475 — — Mortgage Backed Securities - Residential 32,231 72 (292 ) 32,011 — 32,011 — — Mortgage Backed Securities - Commercial 141,988 44 (606 ) 141,426 — 141,426 — — Level 2 Total $ 2,271,311 $ 1,263 $ (5,444 ) $ 2,267,130 $ 7,474 $ 2,259,656 $ — $ — Total $ 4,283,009 $ 4,261 $ (6,352 ) $ 4,280,918 $ 1,501,539 $ 2,574,947 $ 170,969 $ 33,463 June 29, 2014 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Short-Term Restricted Cash & Investments Other (in thousands) Cash $ 285,031 $ — $ — $ 285,031 $ 279,126 $ — $ 5,905 $ — Level 1: Time Deposit 132,549 — — 132,549 — — 132,549 — Money Market Funds 1,168,261 — — 1,168,261 1,168,261 — — — US Treasury and Agencies 212,436 178 (27 ) 212,587 — 204,549 8,038 — Mutual Funds 18,784 2,974 — 21,758 — — — 21,758 Level 1 Total $ 1,532,030 $ 3,152 $ (27 ) $ 1,535,155 $ 1,168,261 $ 204,549 $ 140,587 $ 21,758 Level 2: Municipal Notes and Bonds 334,329 1,108 (4 ) 335,433 5,290 330,143 — — Government-Sponsored Enterprises 27,666 41 (15 ) 27,692 — 27,692 — — Foreign Government Bonds 35,438 57 (28 ) 35,467 — 35,467 — — Corporate Notes and Bonds 874,540 2,034 (335 ) 876,239 — 876,239 — — Mortgage Backed Securities - Residential 27,067 59 (182 ) 26,944 — 26,944 — — Mortgage Backed Securities - Commercial 112,642 100 (809 ) 111,933 — 111,933 — — Level 2 Total $ 1,411,682 $ 3,399 $ (1,373 ) $ 1,413,708 $ 5,290 $ 1,408,418 $ — $ — Total $ 3,228,743 $ 6,551 $ (1,400 ) $ 3,233,894 $ 1,452,677 $ 1,612,967 $ 146,492 $ 21,758 The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. Net realized gains (losses) on investments included other-than-temporary impairment charges of $3.7 million in fiscal year 2013. There were no other-than-temporary impairment charges in fiscal year 2015 or 2014. Additionally, gross realized gains/(losses) from sales of investments were $2.8 million and $(2.1) million in fiscal year 2015, $1.5 million and $(2.0) million in fiscal year 2014, and $1.6 million and $(1.5) million in fiscal year 2013, respectively. The following is an analysis of the Company’s cash, cash equivalents, short-term investments, and restricted cash and investments in unrealized loss positions: June 28, 2015 Unrealized Losses Less Than 12 Months Unrealized Losses 12 Months or Greater Total Fair Value Gross Fair Value Gross Fair Value Gross (in thousands) Municipal Notes and Bonds $ 272,388 $ (335 ) $ — $ — $ 272,388 $ (335 ) US Treasury & Agencies 296,237 (865 ) — — 296,237 (865 ) Retail Funds 3,532 (47 ) — — 3,532 (47 ) Government-Sponsored Enterprises 49,184 (249 ) — — 49,184 (249 ) Foreign Government Bonds 34,882 (161 ) — — 34,882 (161 ) Corporate Notes and Bonds 889,064 (3,750 ) 16,586 (47 ) 905,650 (3,797 ) Mortgage Backed Securities - Residential 20,913 (196 ) 2,190 (96 ) 23,103 (292 ) Mortgage Backed Securities - Commercial 100,388 (431 ) 19,729 (175 ) 120,117 (606 ) $ 1,666,588 $ (6,034 ) $ 38,505 $ (318 ) $ 1,705,093 $ (6,352 ) The amortized cost and fair value of cash equivalents, short-term investments, and restricted cash and investments with contractual maturities are as follows: Cost Estimated Fair (in thousands) Due in one year or less $ 1,651,592 $ 1,651,673 Due after one year through five years 1,944,674 1,940,529 Due in more than five years 379,496 378,590 $ 3,975,762 $ 3,970,792 Management has the ability, if necessary, to liquidate any of its cash equivalents and short-term investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase nonetheless are classified as short-term on the accompanying Consolidated Balance Sheets. Derivative Instruments and Hedging The Company carries derivative financial instruments (“derivatives”) on its Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. The counterparties to these foreign currency forward contracts are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material. Cash Flow Hedges The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-US dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro-denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using foreign currency forward contracts that generally expire within twelve months and no later than 24 months. These foreign currency forward contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized. In addition, during the twelve months ended June 28, 2015, the Company entered into and settled a series of forward-starting interest rate swap agreements, with a total notional value of $375 million, to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. These instruments were designated as cash flow hedges at inception and were settled in conjunction with the issuance of debt during the three months ended March 29, 2015. The effective portion of the contracts’ loss is included in accumulated other comprehensive (loss) and will amortize into income as the hedged item impacts earnings. At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the twelve months ended June 28, 2015 or June 29, 2014 associated with ineffectiveness or forecasted transactions that failed to occur. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of June 28, 2015, the Company had losses of $2.9 million accumulated in other comprehensive income, net of tax, including, $0.2 million gains related to foreign exchange which it expects to reclassify from other comprehensive income into earnings over the next 12 months and $3.1 million losses related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 9.7 years. Balance Sheet Hedges The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. These foreign currency forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). As of June 28, 2015, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program: Derivatives Designated as Derivatives Not Designated as (in thousands) Foreign Currency Forward Contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 18,946 $ — $ 49,924 Swiss franc — — — 3,346 Euro 34,377 — 4,049 — Korean won 7,269 — 8,945 — Taiwan dollar — — 33,239 11,162 $ 41,646 $ 18,946 $ 46,233 $ 64,432 The fair value of derivatives instruments in the Company’s consolidated balance sheet as of June 28, 2015 and June 29, 2014 were as follows: June 28, 2015 June 29, 2014 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Asset Derivatives Liability Asset Derivatives Liability Balance Sheet Fair Balance Fair Balance Sheet Location Fair Balance Location Fair (in thousands) Derivatives designated as hedging instrument Foreign exchange forward contracts Prepaid expense $ 3,388 Accrued $ 957 Prepaid expense $ 483 Accrued $ 805 Derivatives not designated as hedging instrument Foreign exchange forward contracts Prepaid expense 8 Accrued 960 Prepaid expense 1,109 Accrued 118 Total derivatives $ 3,396 $ 1,917 $ 1,592 $ 923 Under the master agreements with the respective counterparties to the Company’s foreign exchange contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis in the Company’s balance sheet. As of June 28, 2015, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $1.9 million, resulting in a net derivative asset of $1.5 million. As of June 29, 2014, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $0.5 million, resulting in a net derivative asset of $1.1 million. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral related to these derivative transactions. The effect of derivative instruments designated as cash flow hedges, before tax, on the Company’s Consolidated Statements of Operations was as follows: Year Ended June 28, 2015 Year Ended June 29, 2014 Location of Effective Portion Ineffective Effective Portion Ineffective Derivatives Designated as Gain (Loss) Gain (Loss) Gain (Loss) Gain Gain Gain (Loss) (in thousands) (in thousands) Foreign Exchange Contracts Revenue $ 13,678 $ 11,375 $ 258 $ 7,939 $ 9,027 $ 277 Foreign Exchange Contracts Cost of goods sold (6,318 ) (4,349 ) (75 ) 812 2,393 (52 ) Foreign Exchange Contracts Selling, general, and administrative (2,579 ) (2,618 ) (39 ) 318 1,087 (23 ) Interest Rate Contracts Other expense, net (5,071 ) (112 ) (231 ) — — — $ (290 ) $ 4,296 $ (87 ) $ 9,069 $ 12,507 $ 202 The effect of derivative instruments not designated as cash flow hedges on the Company’s Consolidated Statement of Operations was as follows: Year Ended June 28, 2015 June 29, 2014 Derivatives Not Designated as Hedging Location of Gain Recognized Gain Gain (in thousands) Foreign Exchange Contracts Other income $ 1,784 $ 8,205 Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short term investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit in large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances. The Company’s over-all portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s or Moody’s Investor Services, respectively. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer. The Company is exposed to credit losses in the event of nonperformance by counterparties on the foreign currency forward contracts that are used to mitigate the effect of exchange rate fluctuations and on contracts related to structured share repurchase agreements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company. Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, ae performed on all new customers and the Company monitors its customers’ financial statements and payment performance. In general, the Company does not require collateral on sales. As of June 28, 2015, four customers accounted for approximately 17%, 13%, 12%, and 11% of accounts receivable. As of June 29, 2014, four customers accounted for approximately 15%, 13%, 12%, and 12% of accounts receivable. No other customers accounted for more than 10% of accounts receivable. |
Inventories
Inventories | 12 Months Ended |
Jun. 28, 2015 | |
Inventories | Note 10: Inventories Inventories are stated at the lower of cost (first-in, first-out method) or market. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following: June 28, June 29, (in thousands) Raw materials $ 566,645 $ 449,623 Work-in-process 141,264 126,564 Finished goods 235,437 164,316 $ 943,346 $ 740,503 |
Property and Equipment
Property and Equipment | 12 Months Ended |
Jun. 28, 2015 | |
Property and Equipment | Note 11: Property and Equipment Property and equipment, net, consist of the following: June 28, June 29, (in thousands) Manufacturing, engineering and office equipment $ 717,788 $ 612,688 Computer equipment and software 137,623 131,184 Land 53,391 52,784 Buildings 238,631 199,544 Leasehold improvements 81,899 80,569 Furniture and fixtures 21,629 20,026 1,250,961 1,096,795 Less: accumulated depreciation and amortization (629,543 ) (553,299 ) $ 621,418 $ 543,496 Depreciation expense, including amortization of capital leases, during fiscal years 2015, 2014, and 2013, was $120.3 million, $129.1 million, and $126.5 million, respectively. During the fiscal year 2015, the Company invested $12.7 million to purchase a commercial building in Fremont, California. During the fiscal year 2014, the Company recorded an $83.1 million gain on sale of real estate in the Consolidated Statement of Operations in fiscal year 2014. No significant gains on sale were realized in fiscal year 2015 or 2013. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Jun. 28, 2015 | |
Goodwill and Intangible Assets | Note 12: Goodwill and Intangible Assets Goodwill The balance of Goodwill decreased to $1.4 billion as of June 28, 2015, as compared to, $1.5 billion as of June 29, 2014. The primarily cause of the decrease was recognition of a $79.4 million impairment on the Company’s single-wafer clean reporting unit during the quarter ended June 28, 2015. Uncertainty surrounding future revenue growth in certain products resulted in the estimated discounted cash flows falling below the carrying value of the goodwill balance. Following fiscal year 2015’s impairment, there is no remaining balance of the Company’s goodwill attributable to the single-wafer clean systems reporting unit. Of the $1.4 billion goodwill balance, $61.1 million is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law. Intangible Assets The following table provides the Company’s intangible assets, other than goodwill, as of June 28, 2015: Gross Accumulated Net (in thousands) Customer relationships $ 615,490 $ (234,968 ) $ 380,522 Existing technology 643,919 (313,071 ) 330,848 Patents 33,553 (26,431 ) 7,122 Other intangible assets 35,914 (35,366 ) 548 Intangible assets subject to amortization 1,328,876 (609,836 ) 719,040 Development rights 9,100 9,100 Intangible assets not subject to amortization 9,100 9,100 Total intangible assets $ 1,337,976 $ (609,836 ) $ 728,140 The following table provides details of the Company’s intangible assets, other than goodwill, as of June 29, 2014: Gross Accumulated Net (in thousands) Customer relationships $ 615,618 $ (169,162 ) $ 446,456 Existing technology 643,922 (224,246 ) 419,676 Patents 32,253 (24,407 ) 7,846 Other intangible assets 35,270 (35,270 ) — Intangible assets subject to amortization 1,327,063 (453,085 ) 873,978 In process research and development 11,000 11,000 Development rights 9,100 9,100 Intangible assets not subject to amortization 20,100 20,100 Total intangible assets $ 1,347,163 $ (453,085 ) $ 894,078 The Company recognized $157.7 million, $163.2 million, and $177.6 million in intangible asset amortization expense during fiscal years 2015, 2014, and 2013, respectively. The Company recognized a $9.8 million impairment of existing technology during the fiscal year 2015, resulting from current market demand for the technology. The Company recognized a $4.0 million impairment of in process research and development during fiscal year 2014, due to the cancellation of a project. The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of June 28, 2015 was as follows: Fiscal Year Amount (in thousands) 2016 $ 156,074 2017 154,122 2018 152,918 2019 114,846 2020 49,700 Thereafter 91,380 $ 719,040 |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 12 Months Ended |
Jun. 28, 2015 | |
Accrued Expenses and Other Current Liabilities | Note 13: Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following: June 28, June 29, (in thousands) Accrued compensation $ 314,516 $ 311,054 Warranty reserves 93,209 68,324 Income and other taxes payable 39,275 93,934 Dividend payable 47,659 29,240 Other 154,779 101,744 $ 649,438 $ 604,296 |
Long Term Debt and Other Borrow
Long Term Debt and Other Borrowings | 12 Months Ended |
Jun. 28, 2015 | |
Long Term Debt and Other Borrowings | Note 14: Long Term Debt and Other Borrowings Convertible Senior Notes In May 2011, the Company issued and sold $450 million in aggregate principal amount of 0.50% Convertible Senior Notes due May 2016 (the “2016 Notes”) at par. At the same time, the Company issued and sold $450 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 0.5% and 1.25%, respectively, on the 2016 Notes and the 2018 Notes, on a semi-annual basis on May 15 and November 15 of each year. In June 2012, with the acquisition of Novellus, the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” collectively with the 2016 Notes and the 2018 Notes, the “Convertible Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year on the 2041 Notes. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes. The Company separately accounts for the liability and equity components of the Convertible Notes. The initial liability components of the Convertible Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the following table, respectively. The equity component was initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount. Under certain circumstances, the Convertible Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the following table. The conversion rates are adjusted for certain corporate events, including dividends on the Company’s Common Stock. At June 28, 2015, the market value of the Company’s Common Stock was greater than 130% of the Convertible Notes conversion prices for 20 or more of the 30 consecutive trading days preceding the quarter end. As a result, the Convertible Notes are convertible at the option of the bondholder. The carrying amount of the Convertible Notes was classified in current liabilities and a portion of the equity component, representing the unamortized debt discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets. Upon closure of the conversion period, the 2018 and 2041 Notes not converted will be reclassified back into noncurrent liabilities, the 2016 Notes will remain in current liabilities due to its scheduled maturity, and the temporary equity will be reclassified into permanent equity. At June 29, 2014 the 2041 Notes were convertible at the option of the bondholder. As of June 28, 2015 and June 29, 2014, the Convertible Notes consisted of the following: June 28, 2015 June 29, 2014 2016 2018 2041 Notes 2016 2018 2041 (in thousands, except years, percentages, conversion rate, and Carrying value, long-term $ — $ — $ — $ 419,561 $ 387,338 $ — Carrying value, current portion 435,493 402,320 520,313 — — 516,586 Unamortized discount 14,507 47,680 179,622 30,439 62,662 183,349 Principal amount $ 450,000 $ 450,000 $ 699,935 $ 450,000 $ 450,000 $ 699,935 Carrying amount of permanent equity component, net of tax $ 61,723 $ 57,215 $ 148,487 $ 76,230 $ 104,895 $ 144,760 Carrying amount of temporary equity component, net of tax $ 14,507 $ 47,679 $ 179,622 $ — $ — $ 183,349 Remaining amortization period (years) 0.9 2.9 25.9 Effective interest rate on liability component 4.29% 5.27% 4.28% Fair Value of Notes (Level 2) $ 604,004 $ 643,500 $ 1,679,844 Conversion rate (shares of common stock per $1,000 principal amount of notes) 16.0806 16.0806 28.8585 Conversion price (per share of common stock) $ 62.19 $ 62.19 $ 34.65 If-converted value in excess of par value $ 149,598 $ 149,598 $ 973,758 Convertible Note Hedges and Warrants Concurrent with the issuance of the 2016 Notes and 2018 Notes, the Company purchased a convertible note hedge and sold warrants. At expiration, the Company may, at its option, elect to settle the warrants on a net share basis. As of June 28, 2015, the warrants had not been exercised and remained outstanding. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. In conjunction with the convertible note hedge, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2016 Notes and 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the 2016 and 2018 Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2016 Notes and 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. The following table presents the details of the warrants and convertible note hedge arrangements as of June 28, 2015: 2016 Notes 2018 Notes (shares in thousands) Warrants: Number of shares to be delivered upon exercise 7,236 7,236 Exercise price $70.40 $75.10 Expiration date range August 15 - October 21, 2016 August 15 - October 23, 2018 Convertible Note Hedge: Number of shares available from counterparties 7,236 7,236 Exercise price $62.19 $62.19 Senior Notes On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March 2020 (the “2020 Notes”) and $500 million aggregate principal amount of the Company’s Senior Notes due March 2025 (the “2025 Notes”, together with the 2020 Notes, the “Senior Notes”). The Company will pay interest at an annual rate of 2.75% and 3.80%, respectively, on the 2020 Notes and 2025 Notes, on a semi-annual basis on March 15 and September 15 of each year, beginning September 15, 2015. The Company may redeem the Senior Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect of the Senior Notes and accrued and unpaid interest before February 15, 2020, for the 2020 Notes and before December 15, 2024, for the 2025 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020 for the 2020 Notes and on or after December 24, 2024 for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes, plus accrued and unpaid interest. As of June 28, 2015 the Senior Notes consisted of the following: June 28, 2015 2020 Notes 2025 Notes (in thousands, except years) Carrying value, long-term $ 497,053 $ 496,907 Unamortized discount 2,947 3,093 Principal amount $ 500,000 $ 500,000 Remaining amortization period (years) 4.7 9.7 Fair Value of Notes (Level 2) $ 497,805 $ 492,945 Interest Cost The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes and the Convertible Notes during the twelve months ended June 29, 2015, June 28, 2014, and June 30, 2013. Twelve Months Ended June 28, June 29, June 30, (in thousands) Contractual interest coupon $ 36,074 $ 26,248 $ 26,248 Amortization of interest discount 34,886 33,065 31,560 Amortization of issuance costs 2,435 2,362 2,362 Amortization of interest rate contract 113 — — Total interest cost recognized $ 73,508 $ 61,675 $ 60,170 Revolving Credit Facility On March 12, 2014, the Company entered into a $300 million revolving unsecured credit facility with a syndicate of lenders. The facility matures on March 12, 2019. The facility includes an option, subject to certain requirements, for the Company to request an increase in the facility of up to an additional $200 million, for a potential total commitment of $500 million. Proceeds from the credit facility can be used for general corporate purposes. Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (ii) LIBOR plus a spread of 0.9% to 1.5%, in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s rating described above. The credit facility contains certain restrictive covenants including maintaining a total consolidated indebtedness to consolidated capitalization ratio of no more than 0.5 to 1.0 and maintaining unrestricted or unencumbered cash and investments of no less than $1.0 billion. As of June 28, 2015, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants. Contractual Obligations The Company’s contractual cash obligations relating to its Convertible Notes and other long-term debt as of June 28, 2015 were as follows: Long-term (in thousands) Payments due by period: 2016* $ 1,599,935 2017 — 2018 — 2019 — 2020 500,000 Thereafter 500,000 Total 2,599,935 Current portion of long-term debt 1,599,935 Long-term debt $ 1,000,000 * As noted above, the conversion periods for the Convertible Notes are open as of June 28, 2015. As there is the potential for conversion at the option of the holder, the principal balance of the 2018 and 2041 Notes have been included in the one year payment period. As of August 6, 2015, none of the Convertible Notes have been converted during fiscal year 2015 or 2014. |
Retirement and Deferred Compens
Retirement and Deferred Compensation Plans | 12 Months Ended |
Jun. 28, 2015 | |
Retirement and Deferred Compensation Plans | Note 15: Retirement and Deferred Compensation Plans Employee Savings and Retirement Plan The Company maintains a 401(k) retirement savings plan for its eligible employees in the United States. Each participant in the plan may elect to contribute from 1% to 75% of annual eligible earnings to the plan, subject to statutory limitations. The Company makes matching employee contributions in cash to the plan at the rate of 50% of the first 6% of earnings contributed. Employees participating in the 401(k) retirement savings plan are fully vested in the Company matching contributions, and investments are directed by participants. The Company made matching contributions of $11.8 million, $10.2 million, and $8.7 million, in fiscal years 2015, 2014, and 2013, respectively. Deferred Compensation Arrangements The Company has an unfunded, non-qualified deferred compensation plan whereby certain executives may defer a portion of their compensation. Participants earn a return on their deferred compensation based on their allocation of their account balance among various mutual funds. The Company controls the investment of these funds and the participants remain general creditors of the Company. Participants are able to elect the payment of benefits on a specified date at least three years after the opening of a deferral subaccount or upon retirement. Distributions are made in the form of lump sum or annual installments over a period of up to 20 years as elected by the participant. If no alternate election has been made, a lump sum payment will be made upon termination of a participant’s employment with the Company. As of June 28, 2015 and June 29, 2014 the liability of the Company to the plan participants was $113.4 million and $93.8 million, respectively, which was recorded in accrued expenses and other current liabilities on the Consolidated Balance Sheets. As of June 28, 2015 and June 29, 2014 the Company had investments in the aggregate amount of $138.9 million and $116.7 million, respectively, which correlate to the deferred compensation obligations, which were recorded in other assets on the Consolidated Balance Sheets. Postretirement Healthcare Plan The Company maintains a postretirement healthcare plan for certain executive and director retirees. Coverage continues through the duration of the lifetime of the retiree or the retiree’s spouse, whichever is longer. The benefit obligation was $30.2 million and $29.0 million as of June 28, 2015 and June 29, 2014, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Jun. 28, 2015 | |
Commitments and Contingencies | Note 16: Commitments and Contingencies The Company has certain obligations to make future payments under various contracts, some of these are recorded on its balance sheet and some are not. Obligations that are recorded on the Company’s balance sheet include the Company’s capital lease obligations. Obligations that are not recorded on the Company’s balance sheet include contractual relationships for operating leases, purchase obligations, and certain guarantees. The Company’s commitments relating to capital leases and off-balance sheet agreements are included in the tables below. These amounts exclude $202.9 million of liabilities related to uncertain tax benefits because the Company is unable to reasonably estimate the ultimate amount or time of settlement. See Note 7 of the Consolidated Financial Statements for further discussion. Capital Leases Capital leases reflect building and office equipment leases. The Company’s contractual cash obligations relating to its existing capital leases, including interest, as of June 28, 2015 were as follows: Capital (in thousands) Payments due by period: 2016 $ 1,630 2017 7,223 2018 77 2019 77 2020 70 Total 9,077 Interest on capital leases 131 Current portion of capital leases 1,524 Long-term portion of capital leases $ 7,422 Operating Leases and Related Guarantees The Company leases the majority of its administrative, R&D and manufacturing facilities, regional sales/service offices and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation. The Company’s rental expense for facilities occupied during fiscal years 2015, 2014, and 2013 was approximately $15 million, $12 million, and $14 million, respectively. The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $132.5 million in separate interest-bearing accounts, and marketable securities collateral in an aggregate of approximately $32.9 million, as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Consolidated Balance Sheet as of June 28, 2015. During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than $219.0 million; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $249.9 million, in the aggregate. The Company’s contractual cash obligations with respect to operating leases, excluding the residual value guarantees discussed above, as of June 28, 2015 were as follows: Operating (in thousands) Payments due by period: 2016 $ 17,593 2017 14,004 2018 6,544 2019 5,223 2020 4,847 thereafter 10,811 Less: Sublease Income (478 ) Total $ 58,544 Other Guarantees The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of June 28, 2015, the Company had not recorded any liability on its Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any amounts will be paid under these guarantees. Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees. The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of June 28, 2015, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $15.5 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid. Purchase Obligations Purchase obligations consist of non-cancelable significant contractual obligations either on an annual basis or over multi-year periods. The contractual cash obligations and commitments table presented below contains the Company’s minimum obligations at June 28, 2015 under these arrangements and others. For obligations with cancellation provisions, the amounts included in the following table were limited to the non-cancelable portion of the agreement terms or the minimum cancellation fee. Actual expenditures will vary based on the volume of transactions and length of contractual service provided. The Company’s commitments related to these agreements as of June 28, 2015 were as follows: Purchase (in thousands) Payments due by period: 2016 $ 189,955 2017 980 2018 980 2019 970 2020 970 Total $ 193,855 Warranties The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. Changes in the Company’s product warranty reserves were as follows: Year Ended June 28, June 29, (in thousands) Balance at beginning of period $ 69,385 $ 58,078 Warranties issued during the period 119,119 87,922 Settlements made during the period (100,196 ) (80,280 ) Changes in liability for pre-existing warranties 4,901 3,665 Balance at end of period $ 93,209 $ 69,385 Legal Proceedings While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company believes that the amount of any such additional loss would be immaterial to the Company’s business, financial condition, and results of operations. |
Stock Repurchase Program
Stock Repurchase Program | 12 Months Ended |
Jun. 28, 2015 | |
Stock Repurchase Program | Note 17: Stock Repurchase Program On April 29, 2014, the Board of Directors authorized the repurchase of up to $850 million of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases are funded using the Company’s on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time. Repurchases under the repurchase program were as follows during the periods indicated: Period Total Number Total Average Amount Available (in thousands, except per share data) Available balance as of June 29, 2014 $ 830,895 Quarter ended September 28, 2014 3,818 $ 296,721 $ 70.01 $ 534,174 Quarter ended December 28, 2014 869 $ 45,694 $ 77.31 $ 488,480 Quarter ended March 29, 2015 1,434 $ 112,477 $ 78.45 $ 376,003 Quarter ended June 28, 2015 754 $ 59,416 $ 78.80 $ 316,587 * Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See the section below for discussion regarding average price associated with the transaction. In addition to shares repurchased under the Board-authorized repurchase program shown above, the Company acquired 761,883 shares at a total cost of $58.8 million, during the twelve months ended June 28, 2015, which the Company withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plans. As part of its share repurchase program, the Company may from time-to-time enter into structured share repurchase arrangements with financial institutions using general corporate funds. During the three months ended September 28, 2014, the Company entered into a collared accelerated share repurchase (“ASR”) transaction under a master repurchase arrangement. Under the ASR, the Company made an up-front cash payment of $250 million, in exchange for an initial delivery of approximately 3.2 million shares of its Common Stock. The number of shares to ultimately be repurchased by the Company was based generally on the volume-weighted average price (“VWAP”) of the Common Stock during the term of the ASR minus a pre-determined discount set at inception of the ASR, subject to collar provisions that provided a minimum and maximum number of shares that the Company could repurchase under the agreements. The minimum and maximum thresholds for the transaction were established based on the average of the VWAP prices for the Common Stock during an initial hedge period. The ASR was scheduled to end at any time on or after October 8, 2014 and on or before December 8, 2014. The counterparty designated October 9, 2014 as the termination date, at which time the Company settled the ASR. Approximately 0.3 million shares were received at final settlement, which represented a weighted-average share price of approximately $72.90 for the transaction period. |
Comprehensive Income (Loss)
Comprehensive Income (Loss) | 12 Months Ended |
Jun. 28, 2015 | |
Comprehensive Income (Loss) | Note 18: Comprehensive Income (Loss) The components of accumulated other comprehensive loss, net of tax at the end of the period, as well as the activity during the period, were as follows: Accumulated Accumulated Accumulated Accumulated Total (in thousands) Balance as of June 29, 2014 $ (12,986 ) $ (66 ) $ 1,557 $ (17,160 ) $ (28,655 ) Other comprehensive income (loss) before reclassifications (18,438 ) 1,595 (5,389 ) 1,109 (21,123 ) (Gains) losses reclassified from accumulated other comprehensive income (loss) to net income (3,701 ) (4,388 )(1) 71 (2) — (8,018 ) Net current-period other comprehensive income (loss) $ (22,139 ) $ (2,793 ) $ (5,318 ) $ 1,109 $ (29,141 ) Balance as of June 28, 2015 $ (35,125 ) $ (2,859 ) $ (3,761 ) $ (16,051 ) $ (57,796 ) (1) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $10,136 gain, cost of goods sold: $3,704 loss, selling, general and administrative expenses: $1,974 loss, and other income and expense: $70 Loss (2) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net Tax related to the components of other comprehensive income during the period were as follows: Year Ended June 28, June 29, June 30, (in thousands) Tax benefit (expense) on change in unrealized gains/losses on cash flow hedges: Tax benefit (expense) on unrealized gains/losses arising during the period $ 1,885 $ (1,065 ) $ (1,312 ) Tax (benefit) expense on gains/losses reclassified to earnings (92 ) 1,615 818 1,793 550 (494 ) Tax benefit (expense) on change in unrealized gains/losses on available-for-sale investments: Tax benefit (expense) on unrealized gains/losses arising during the period 1,796 (735 ) 1,428 Tax (benefit) expense on gains/losses reclassified to earnings 31 493 (2,026 ) 1,827 (242 ) (598 ) Tax benefit (expense) on change in unrealized components of defined benefit plans (871 ) 1,895 586 Tax benefit (expense) on other comprehensive income(loss) $ 2,749 $ 2,203 $ (506 ) |
Segment, Geographic Information
Segment, Geographic Information and Major Customers | 12 Months Ended |
Jun. 28, 2015 | |
Segment, Geographic Information and Major Customers | Note 19: Segment, Geographic Information and Major Customers The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing and distribution. The Company operates in seven geographic regions: United States, Europe, Japan, Korea, Taiwan, China and Southeast Asia. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located while long-lived assets are attributed to the geographic locations in which the assets are located. Revenues and long-lived assets by geographic region were as follows: Year Ended June 28, June 29, June 30, (in thousands) Revenue: Korea $ 1,406,617 $ 1,127,406 $ 603,821 Taiwan 1,084,239 1,049,214 1,026,548 United States 890,891 622,022 734,324 China 661,094 623,408 319,282 Japan 623,575 634,131 368,095 Europe 314,546 303,730 292,432 Southeast Asia 278,350 247,398 254,414 Total revenue $ 5,259,312 $ 4,607,309 $ 3,598,916 June 28, June 29, June 30, (in thousands) Long-lived assets: United States $ 505,814 $ 429,548 $ 484,273 Europe 86,779 89,221 109,934 Korea 18,230 18,776 991 Taiwan 8,908 4,259 2,953 China 960 846 2,291 Japan 378 454 680 Southeast Asia 349 392 2,788 $ 621,418 $ 543,496 $ 603,910 In fiscal year 2015, three customers accounted for approximately 28%, 12%, and 11% of total revenues. In fiscal year 2014, three customers accounted for approximately 23%, 15%, and 14% of total revenues. In fiscal year 2013, three customers accounted for approximately 19%, 15%, and 11% of total revenues. No other customers accounted for more than 10% of total revenues. |
Summary of Significant Accoun28
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Jun. 28, 2015 | |
Revenue Recognition | Revenue Recognition: |
Inventory Valuation | Inventory Valuation: Management evaluates the need to record adjustments for impairment of inventory at least quarterly. The Company’s policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated market value if less than cost. Estimates of market value include, but are not limited to, management’s forecasts related to the Company’s future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future customer demand or market conditions are less favorable than the Company’s projections, additional inventory write-downs may be required and would be reflected in cost of goods sold in the period in which the revision is made. |
Warranty | Warranty: While the Company periodically monitors the performance and cost of warranty activities, if actual costs incurred are different than its estimates, the Company may recognize adjustments to provisions in the period in which those differences arise or are identified. In addition to the provision of standard warranties, the Company offers customer-paid extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded as incurred. |
Equity-based Compensation - Employee Stock Purchase Plan ("ESPP") and Employee Stock Plans | Equity-based Compensation — Employee Stock Purchase Plan (“ESPP”) and Employee Stock Plans: The Company makes quarterly assessments of the adequacy of its tax credit pool related to equity-based compensation to determine if there are any deficiencies that it is required to recognize in the Company’s Condensed Consolidated Statements of Operations. The Company will only recognize a benefit from equity-based compensation in paid-in-capital if it realizes an incremental tax benefit after all other tax attributes currently available to us have been utilized. In addition, the Company has elected to account for the indirect benefits of equity-based compensation on the research tax credit through the income statement rather than through paid-in-capital. The Company also elected to net deferred tax assets and the associated valuation allowance related to net operating loss and tax credit carryforwards for the accumulated stock award tax benefits for income tax footnote disclosure purposes. The Company tracks these stock award attributes separately and will only recognize these attributes through paid-in-capital. |
Income Taxes | Income Taxes: The Company recognizes the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. The Company’s policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense. |
Goodwill and Intangible Assets | Goodwill and Intangible Assets: Goodwill represents the amount by which the purchase price in each business combination exceeds the fair value of the net tangible and identifiable intangible assets acquired. Each component of the Company for which discrete financial information is available and for which management regularly reviews the results of operations is considered a reporting unit. All goodwill acquired in a business combination is assigned to one or more reporting units as of the acquisition date. Goodwill is assigned to the Company’s reporting units that are expected to benefit from the synergies of the combination. The goodwill assigned to a reporting unit is the difference between the acquisition consideration assigned to the reporting unit on a relative fair value basis and the fair value of acquired assets and liabilities that can be specifically attributed to the reporting unit. The Company tests goodwill and identifiable intangible assets with indefinite useful lives for impairment at least annually. The Company amortizes intangible assets with estimable useful lives over their respective estimated useful lives, and the Company reviews for impairment whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable and the carrying amount exceeds its fair value. The Company reviews goodwill at least annually for impairment. If certain events or indicators of impairment occur between annual impairment tests, the Company would perform an impairment test at that date. In testing for a potential impairment of goodwill, the Company: (1) allocates goodwill to its reporting units to which the acquired goodwill relates; (2) estimates the fair value of its reporting units; and (3) determines the carrying value (book value) of those reporting units. Furthermore, if the estimated fair value of a reporting unit is less than the carrying value, the Company must estimate the fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require independent valuations of certain internally generated and unrecognized intangible assets such as in-process R&D and developed technology. Only after this process is completed can the amount of goodwill impairment, if any, be determined. In the Company’s goodwill impairment process it first assesses qualitative factors to determine whether it is necessary to perform a quantitative analysis. The Company does not calculate the fair value of a reporting unit unless the Company determines, based on a qualitative assessment, that it is more-likely-than-not that its fair value is less than its carrying amount. The Company performed the most recent annual goodwill impairment analysis as of the first day of its fourth quarter of fiscal year 2015, March 30, 2015, resulted in an impairment charge on the Company’s single-wafer clean reporting unit of approximately $79.4 million. The Company did not record any goodwill impairment in fiscal years 2014 or 2013. The process of evaluating the potential impairment of goodwill is subjective and requires significant judgment at many points during the analysis. The Company determines the fair value of its reporting units by using an income approach. Under the income approach, the Company determines fair value based on estimated future cash flows of each reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit and the rate of return an outside investor would expect to earn. In estimating the fair value of a reporting unit, the Company makes estimates and judgments about the future cash flows of its reporting units, including estimated growth rates and assumptions about the economic environment. Although the Company’s cash flow forecasts are based on assumptions that are consistent with the plans and estimates it is using to manage the underlying businesses, there is significant judgment involved in determining the cash flows attributable to a reporting unit. In addition, the Company makes certain judgments about allocating shared assets to the estimated balance sheets of its reporting units. Changes in judgment on these assumptions and estimates could result in a goodwill impairment charge. As a result, several factors could result in impairment of a material amount of the Company’s goodwill balance in future periods, including, but not limited to: (1) weakening of the global economy, weakness in the semiconductor equipment industry, or failure of the Company to reach its internal forecasts, which could impact the Company’s ability to achieve its forecasted levels of cash flows and reduce the estimated discounted cash flow value of its reporting units; and (2) a decline in the Company’s stock price and resulting market capitalization, and to the extent the Company determines that the decline is sustained and indicates a reduction in the fair value of the Company’s reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, is based on estimates and judgments regarding expectations such as the success and life cycle of products and technology acquired. If actual product acceptance differs significantly from the estimates, the Company may be required to record an impairment charge to write down the asset to its realizable value. The Company reviews indefinite-lived intangible assets for an impairment annually, or when events or circumstances indicate the carrying value may not be recoverable. Factors that may be a change in circumstances, indicating the carrying value of amortizable intangible assets may not be recoverable, include a reduced future cash flow estimate, and slower growth rates in the industry segment in which the Company participates. The Company determines whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying value. If the sum is less, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. The Company recognizes an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The Company recognized a $4.0 million impairment charge related to indefinite-lived intangible asset during the year ended June 29, 2014. The Company did not record an impairment charge on indefinite-lived intangible assets during the years ended June 28, 2015 or June 30, 2013. |
Impairment of Long-Lived Assets (Excluding Goodwill and indefinite-lived Intangibles) | Impairment of Long-Lived Assets (Excluding Goodwill and indefinite-lived Intangibles): |
Fiscal Year | Fiscal Year: |
Principles of Consolidation | Principles of Consolidation: |
Cash Equivalents and Short-Term Investments | Cash Equivalents and Short-Term Investments: |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts: |
Property and Equipment | Property and Equipment: |
Derivative Financial Instruments | Derivative Financial Instruments: To hedge foreign currency risks, the Company uses foreign currency exchange forward contracts, where possible and prudent. These forward contracts are valued using standard valuation formulas with assumptions about future foreign currency exchange rates derived from existing exchange rates, interest rates, and other market factors. The Company considers its most current forecast in determining the level of foreign currency denominated revenue and expenses to hedge as cash flow hedges. The Company combines these forecasts with historical trends to establish the portion of its expected volume to be hedged. The revenue and expenses are hedged and designated as cash flow hedges to protect the Company from exposures to fluctuations in foreign currency exchange rates. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge gains and losses on the cash flow hedge are reclassified from accumulated other comprehensive income (loss) to other income (expense), net on the consolidated statement of operations at that time. |
Guarantees | Guarantees: |
Foreign Currency Translation | Foreign Currency Translation: |
Equity-Based Compensation Pla29
Equity-Based Compensation Plans (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Recognized Equity Based Compensation Expenses and Benefits | The Company recognized the following equity-based compensation expense and benefits in the Condensed Consolidated Statements of Operations: Year Ended June 28, June 29, June 30, (in thousands) Equity-based compensation expense $ 135,354 $ 103,700 $ 99,310 Income tax benefit recognized in the related to equity-based compensation $ 23,660 $ 16,937 $ 17,647 Income tax benefit realized from the exercise and vesting of options and RSUs $ 40,401 $ 31,993 $ 21,625 |
Summary of Stock Plan Activity | A summary of stock plan transactions is as follows: Options Outstanding Restricted Stock Units Outstanding Number of Weighted-Average Price Number of Weighted-Average June 24, 2012 3,902,077 $ 25.14 4,331,478 $ 41.01 Granted 288,867 $ 42.59 2,563,670 $ 38.76 Exercised (1,546,028 ) $ 25.47 N/A N/A Canceled (73,993 ) $ 26.24 (299,079 ) $ 39.70 Vested restricted stock N/A N/A (1,754,273 ) $ 42.52 June 30, 2013 2,570,923 $ 26.87 4,841,796 $ 39.32 Granted 166,455 $ 51.76 2,811,602 $ 53.21 Exercised (1,403,019 ) $ 24.75 N/A N/A Canceled (2,473 ) $ 30.21 (281,476 ) $ 41.16 Vested restricted stock N/A N/A (1,736,453 ) $ 40.39 June 29, 2014 1,331,886 $ 32.20 5,635,469 $ 45.83 Granted 76,659 $ 80.60 1,804,937 $ 79.74 Exercised (564,558 ) $ 31.05 N/A N/A Cancelled (8,155 ) $ 29.32 (174,879 ) $ 50.16 Vested restricted stock N/A N/A (2,311,439 ) $ 41.17 June 28, 2015 835,832 $ 37.44 4,954,088 $ 60.13 |
Outstanding and Exercisable Options by Price Range | Outstanding and exercisable options presented by price range at June 28, 2015 were as follows: Options Outstanding Options Exercisable Range of Exercise Prices Number of Weighted-Average Weighted-Average Number of Weighted-Average $9.44-$19.05 130,682 0.52 $ 12.94 130,682 $ 12.94 $21.04-$25.60 89,907 0.30 $ 22.13 86,845 $ 22.08 $26.87-$29.68 193,978 0.86 $ 29.26 190,025 $ 29.32 $31.45-$35.68 30,042 0.21 $ 32.94 30,042 $ 32.94 $42.41-$80.60 391,223 2.53 $ 53.54 185,101 $ 43.58 $9.44-$51.76 835,832 4.42 $ 37.44 622,695 $ 29.29 |
Schedule of Stock Options Weighted Average Assumptions | Year Ended June 28, June 29, June 30, Expected volatility 34.45% 35.28% 36.60% Risk-free interest rate 1.46% 1.39% 0.81% Expected term (years) 4.80 4.78 4.79 Dividend yield 0.89% — — |
Intrinsic Value of Stock Options | The year-end intrinsic value relating to stock options for fiscal years 2015, 2014, and 2013 is presented below: Year Ended June 28, June 29, June 30, (in thousands) Intrinsic value - options outstanding $ 37,961 $ 46,283 $ 44,919 Intrinsic value - options exercisable $ 33,360 $ 31,653 $ 36,870 Intrinsic value - options exercised $ 26,806 $ 41,379 $ 25,430 |
Schedule of Market-Based Performance Restricted Stock Units Weighted Average Assumptions | The fair value of the Company’s market-based PRSUs granted during fiscal years 2015 and 2014, was calculated using a Monte Carlo simulation model at the date of the grant. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award: Year Ended June 28, June 29, Expected volatility 27.93% 29.27% Risk-free interest rate 1.05% 0.55% Expected term (years) 2.98 2.67 Dividend yield 0.89% — |
Schedule of ESPP Weighted-Average Assumptions | The 1999 ESPP rights were valued using the Black-Scholes model. During fiscal years 2015, 2014, and 2013, the 1999 ESPP was valued using the following weighted-average assumptions: Year Ended June 28, June 29, June 30, Expected term (years) 0.67 0.68 0.64 Expected stock price volatility 27.60% 30.24% 32.42% Risk-free interest rate 0.07% 0.07% 0.15% Dividend Yield 0.69% — — |
Other Income (Expense), Net (Ta
Other Income (Expense), Net (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Components of Other Income (Expense), Net | The significant components of other income (expense), net, were as follows: Year Ended June 28, June 29, June 30, (in thousands) Interest income $ 19,268 $ 12,540 $ 14,737 Interest expense (73,682 ) (61,692 ) (60,408 ) Gains on deferred compensation plan related assets, net 9,071 9,559 9,764 Foreign exchange gains (losses), net 2,331 1,529 (6,808 ) Other, net (4,177 ) 668 (8,698 ) $ (47,189 ) $ (37,396 ) $ (51,413 ) |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Income Loss Before Income Taxes | The components of income (loss) before income taxes were as follows: June 28, June 29, June 30, (in thousands) United States $ 72,728 $ 78,076 $ (46,392 ) Foreign 668,122 645,287 113,050 $ 740,850 $ 723,363 $ 66,658 |
Provision Benefit For Income Taxes | Significant components of the provision (benefit) for income taxes attributable to income before income taxes were as follows: June 28, June 29, June 30, (in thousands) Federal: Current $ 16,795 $ 31,762 $ (1,096 ) Deferred 12,115 10,692 (60,172 ) $ 28,910 $ 42,454 $ (61,268 ) State: Current $ 1,376 $ 3,192 $ 3,332 Deferred 158 (869 ) (6,351 ) $ 1,534 $ 2,323 $ (3,019 ) Foreign: Current $ 61,551 $ 49,273 $ 20,640 Deferred (6,722 ) (2,976 ) (3,574 ) $ 54,829 $ 46,297 $ 17,066 Total Provision (Benefit) for Income Taxes $ 85,273 $ 91,074 $ (47,221 ) |
Components of Net Deferred Tax Assets | Significant components of the Company’s net deferred tax assets and liabilities were as follows: June 28, June 29, (in thousands) Deferred tax assets: Tax carryforwards $ 129,234 $ 170,028 Allowances and reserves 131,079 126,895 Equity-based compensation 21,086 18,019 Inventory valuation differences 15,167 16,257 Other 13,942 12,661 Gross deferred tax assets 310,508 343,860 Valuation allowance (85,620 ) (74,439 ) Net deferred tax assets 224,888 269,421 Deferred tax liabilities: Intangible Assets (64,725 ) (87,329 ) Convertible debt (130,991 ) (117,112 ) Temporary differences for captial assets (37,635 ) (32,350 ) Amortization of goodwill (12,502 ) (11,409 ) Unremitted earnings of foreign subsidiaries (66,412 ) (40,286 ) Other (6,100 ) (5,673 ) Gross deferred tax liabilities (318,365 ) (294,159 ) Net deferred tax liabilities $ (93,477 ) $ (24,738 ) |
Reconciliation of Income Tax Expense Provided at Federal Statutory Rate to Actual Income Expense | A reconciliation of income tax expense provided at the federal statutory rate (35% in fiscal years 2015, 2014, and 2013) to actual income tax expense (benefit) is as follows: June 28, June 29, June 30, (in thousands) Income tax expense computed at federal statutory rate $ 259,297 $ 253,177 $ 23,332 State income taxes, net of federal tax benefit (8,611 ) 1,884 (13,588 ) Foreign income taxed at different rates (175,581 ) (164,130 ) (40,255 ) Tax credits (24,416 ) (15,650 ) (42,593 ) State valuation allowance, net of federal tax benefit 8,594 (1,707 ) 11,538 Equity-based compensation 28,845 23,167 20,318 Other permanent differences and miscellaneous items (2,855 ) (5,667 ) (5,973 ) $ 85,273 $ 91,074 $ (47,221 ) |
Changes in Balance of Gross Unrecognized Tax Benefits | The aggregate changes in the balance of gross unrecognized tax benefits were as follows: (in thousands) Balance as of June 24, 2012 $ 343,837 Settlements and effective settlements with tax authorities (3,422 ) Lapse of statute of limitations (51,422 ) Increases in balances related to tax positions taken during prior periods 11,352 Decreases in balances related to tax positions taken during prior periods (11,281 ) Increases in balances related to tax positions taken during current period 35,170 Tax positions assumed in Novellus transaction 8,880 Balance as of June 30, 2013 333,114 Lapse of statute of limitations (16,048 ) Increases in balances related to tax positions taken during prior periods 6,225 Decreases in balances related to tax positions taken during prior periods (4,182 ) Increases in balances related to tax positions taken during current period 33,003 Balance as of June 29, 2014 352,112 Settlements and effective settlements with tax authorities (2,108 ) Lapse of statute of limitations (9,376 ) Increases in balances related to tax positions taken during prior periods 3,729 Decreases in balances related to tax positions taken during prior periods (12,615 ) Increases in balances related to tax positions taken during current period 31,810 Balance as of June 28, 2015 $ 363,552 |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share | The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. Year Ended June 28, June 29, June 30, (in thousands, except per share data) Numerator: Net income $ 655,577 $ 632,289 $ 113,879 Denominator: Basic average shares outstanding 159,629 164,741 168,932 Effect of potential dilutive securities: Employee stock plans 3,193 2,864 2,558 Convertible notes 13,530 6,898 1,940 Warrants 715 — — Diluted average shares outstanding 177,067 174,503 173,430 Net income per share - basic $ 4.11 $ 3.84 $ 0.67 Net income per share - diluted $ 3.70 $ 3.62 $ 0.66 |
Schedule of Potentially Dilutive Securities Excluded from EPS Calculations | The following potentially dilutive securities were excluded: Year Ended June 28, June 29, June 30, (in thousands) Number of options and RSUs excluded 330 78 534 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Cash, Cash Equivalents, Short-Term Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis | The following table sets forth the Company’s cash, cash equivalents, short-term investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of June 28, 2015 and June 29, 2014: June 28, 2015 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Short-Term Restricted Investments Other (in thousands) Cash $ 276,663 $ — $ — $ 276,663 $ 271,452 $ — $ 5,211 $ — Level 1: Time Deposit 177,567 — — 177,567 44,738 — 132,829 — Money Market Funds 1,177,875 — — 1,177,875 1,177,875 — — — US Treasury and Agencies 349,009 72 (861 ) 348,220 — 315,291 32,929 — Mutual Funds 30,584 2,926 (47 ) 33,463 — — — 33,463 Level 1 Total $ 1,735,035 $ 2,998 $ (908 ) $ 1,737,125 $ 1,222,613 $ 315,291 $ 165,758 $ 33,463 Level 2: Municipal Notes and Bonds 659,550 429 (335 ) 659,644 7,474 652,170 — — US Treasuries and Agencies 4,007 — (4 ) 4,003 — 4,003 — — Government-Sponsored Enterprises 53,612 2 (249 ) 53,365 — 53,365 — — Foreign Government Bonds 50,336 31 (161 ) 50,206 — 50,206 — — Corporate Notes and Bonds 1,329,587 685 (3,797 ) 1,326,475 — 1,326,475 — — Mortgage Backed Securities - Residential 32,231 72 (292 ) 32,011 — 32,011 — — Mortgage Backed Securities - Commercial 141,988 44 (606 ) 141,426 — 141,426 — — Level 2 Total $ 2,271,311 $ 1,263 $ (5,444 ) $ 2,267,130 $ 7,474 $ 2,259,656 $ — $ — Total $ 4,283,009 $ 4,261 $ (6,352 ) $ 4,280,918 $ 1,501,539 $ 2,574,947 $ 170,969 $ 33,463 June 29, 2014 (Reported Within) Cost Unrealized Unrealized Fair Value Cash and Short-Term Restricted Cash & Investments Other (in thousands) Cash $ 285,031 $ — $ — $ 285,031 $ 279,126 $ — $ 5,905 $ — Level 1: Time Deposit 132,549 — — 132,549 — — 132,549 — Money Market Funds 1,168,261 — — 1,168,261 1,168,261 — — — US Treasury and Agencies 212,436 178 (27 ) 212,587 — 204,549 8,038 — Mutual Funds 18,784 2,974 — 21,758 — — — 21,758 Level 1 Total $ 1,532,030 $ 3,152 $ (27 ) $ 1,535,155 $ 1,168,261 $ 204,549 $ 140,587 $ 21,758 Level 2: Municipal Notes and Bonds 334,329 1,108 (4 ) 335,433 5,290 330,143 — — Government-Sponsored Enterprises 27,666 41 (15 ) 27,692 — 27,692 — — Foreign Government Bonds 35,438 57 (28 ) 35,467 — 35,467 — — Corporate Notes and Bonds 874,540 2,034 (335 ) 876,239 — 876,239 — — Mortgage Backed Securities - Residential 27,067 59 (182 ) 26,944 — 26,944 — — Mortgage Backed Securities - Commercial 112,642 100 (809 ) 111,933 — 111,933 — — Level 2 Total $ 1,411,682 $ 3,399 $ (1,373 ) $ 1,413,708 $ 5,290 $ 1,408,418 $ — $ — Total $ 3,228,743 $ 6,551 $ (1,400 ) $ 3,233,894 $ 1,452,677 $ 1,612,967 $ 146,492 $ 21,758 |
Schedule of Cash, Cash Equivalents, Short-Term Investments and Restricted Cash and Investments in Unrealized Loss Positions | The following is an analysis of the Company’s cash, cash equivalents, short-term investments, and restricted cash and investments in unrealized loss positions: June 28, 2015 Unrealized Losses Less Than 12 Months Unrealized Losses 12 Months or Greater Total Fair Value Gross Fair Value Gross Fair Value Gross (in thousands) Municipal Notes and Bonds $ 272,388 $ (335 ) $ — $ — $ 272,388 $ (335 ) US Treasury & Agencies 296,237 (865 ) — — 296,237 (865 ) Retail Funds 3,532 (47 ) — — 3,532 (47 ) Government-Sponsored Enterprises 49,184 (249 ) — — 49,184 (249 ) Foreign Government Bonds 34,882 (161 ) — — 34,882 (161 ) Corporate Notes and Bonds 889,064 (3,750 ) 16,586 (47 ) 905,650 (3,797 ) Mortgage Backed Securities - Residential 20,913 (196 ) 2,190 (96 ) 23,103 (292 ) Mortgage Backed Securities - Commercial 100,388 (431 ) 19,729 (175 ) 120,117 (606 ) $ 1,666,588 $ (6,034 ) $ 38,505 $ (318 ) $ 1,705,093 $ (6,352 ) |
Schedule of Amortized Cost and Fair Value of Cash Equivalents, Short-Term Investments, Restricted Cash and Investments with Contractual Maturities | The amortized cost and fair value of cash equivalents, short-term investments, and restricted cash and investments with contractual maturities are as follows: Cost Estimated Fair (in thousands) Due in one year or less $ 1,651,592 $ 1,651,673 Due after one year through five years 1,944,674 1,940,529 Due in more than five years 379,496 378,590 $ 3,975,762 $ 3,970,792 |
Schedule of Outstanding Foreign Currency Forward Contracts | As of June 28, 2015, the Company had the following outstanding foreign currency forward contracts that were entered into under its cash flow and balance sheet hedge program: Derivatives Designated as Derivatives Not Designated as (in thousands) Foreign Currency Forward Contracts Buy Contracts Sell Contracts Buy Contracts Sell Contracts Japanese yen $ — $ 18,946 $ — $ 49,924 Swiss franc — — — 3,346 Euro 34,377 — 4,049 — Korean won 7,269 — 8,945 — Taiwan dollar — — 33,239 11,162 $ 41,646 $ 18,946 $ 46,233 $ 64,432 |
Schedule of Fair Value of Derivatives Instruments | The fair value of derivatives instruments in the Company’s consolidated balance sheet as of June 28, 2015 and June 29, 2014 were as follows: June 28, 2015 June 29, 2014 Fair Value of Derivative Instruments (Level 2) Fair Value of Derivative Instruments (Level 2) Asset Derivatives Liability Asset Derivatives Liability Balance Sheet Fair Balance Fair Balance Sheet Location Fair Balance Location Fair (in thousands) Derivatives designated as hedging instrument Foreign exchange forward contracts Prepaid expense $ 3,388 Accrued $ 957 Prepaid expense $ 483 Accrued $ 805 Derivatives not designated as hedging instrument Foreign exchange forward contracts Prepaid expense 8 Accrued 960 Prepaid expense 1,109 Accrued 118 Total derivatives $ 3,396 $ 1,917 $ 1,592 $ 923 |
Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations | The effect of derivative instruments designated as cash flow hedges, before tax, on the Company’s Consolidated Statements of Operations was as follows: Year Ended June 28, 2015 Year Ended June 29, 2014 Location of Effective Portion Ineffective Effective Portion Ineffective Derivatives Designated as Gain (Loss) Gain (Loss) Gain (Loss) Gain Gain Gain (Loss) (in thousands) (in thousands) Foreign Exchange Contracts Revenue $ 13,678 $ 11,375 $ 258 $ 7,939 $ 9,027 $ 277 Foreign Exchange Contracts Cost of goods sold (6,318 ) (4,349 ) (75 ) 812 2,393 (52 ) Foreign Exchange Contracts Selling, general, and administrative (2,579 ) (2,618 ) (39 ) 318 1,087 (23 ) Interest Rate Contracts Other expense, net (5,071 ) (112 ) (231 ) — — — $ (290 ) $ 4,296 $ (87 ) $ 9,069 $ 12,507 $ 202 The effect of derivative instruments not designated as cash flow hedges on the Company’s Consolidated Statement of Operations was as follows: Year Ended June 28, 2015 June 29, 2014 Derivatives Not Designated as Hedging Location of Gain Recognized Gain Gain (in thousands) Foreign Exchange Contracts Other income $ 1,784 $ 8,205 |
Inventories (Tables)
Inventories (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Inventories | Inventories consist of the following: June 28, June 29, (in thousands) Raw materials $ 566,645 $ 449,623 Work-in-process 141,264 126,564 Finished goods 235,437 164,316 $ 943,346 $ 740,503 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Property and Equipment Net | Property and equipment, net, consist of the following: June 28, June 29, (in thousands) Manufacturing, engineering and office equipment $ 717,788 $ 612,688 Computer equipment and software 137,623 131,184 Land 53,391 52,784 Buildings 238,631 199,544 Leasehold improvements 81,899 80,569 Furniture and fixtures 21,629 20,026 1,250,961 1,096,795 Less: accumulated depreciation and amortization (629,543 ) (553,299 ) $ 621,418 $ 543,496 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Intangible Assets, Other Than Goodwill | The following table provides the Company’s intangible assets, other than goodwill, as of June 28, 2015: Gross Accumulated Net (in thousands) Customer relationships $ 615,490 $ (234,968 ) $ 380,522 Existing technology 643,919 (313,071 ) 330,848 Patents 33,553 (26,431 ) 7,122 Other intangible assets 35,914 (35,366 ) 548 Intangible assets subject to amortization 1,328,876 (609,836 ) 719,040 Development rights 9,100 9,100 Intangible assets not subject to amortization 9,100 9,100 Total intangible assets $ 1,337,976 $ (609,836 ) $ 728,140 The following table provides details of the Company’s intangible assets, other than goodwill, as of June 29, 2014: Gross Accumulated Net (in thousands) Customer relationships $ 615,618 $ (169,162 ) $ 446,456 Existing technology 643,922 (224,246 ) 419,676 Patents 32,253 (24,407 ) 7,846 Other intangible assets 35,270 (35,270 ) — Intangible assets subject to amortization 1,327,063 (453,085 ) 873,978 In process research and development 11,000 11,000 Development rights 9,100 9,100 Intangible assets not subject to amortization 20,100 20,100 Total intangible assets $ 1,347,163 $ (453,085 ) $ 894,078 |
Estimated Future Amortization Expense of Intangible Assets | The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of June 28, 2015 was as follows: Fiscal Year Amount (in thousands) 2016 $ 156,074 2017 154,122 2018 152,918 2019 114,846 2020 49,700 Thereafter 91,380 $ 719,040 |
Accrued Expenses and Other Cu37
Accrued Expenses and Other Current Liabilities (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consist of the following: June 28, June 29, (in thousands) Accrued compensation $ 314,516 $ 311,054 Warranty reserves 93,209 68,324 Income and other taxes payable 39,275 93,934 Dividend payable 47,659 29,240 Other 154,779 101,744 $ 649,438 $ 604,296 |
Long Term Debt and Other Borr38
Long Term Debt and Other Borrowings (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Components of Convertible Notes | As of June 28, 2015 and June 29, 2014, the Convertible Notes consisted of the following: June 28, 2015 June 29, 2014 2016 2018 2041 Notes 2016 2018 2041 (in thousands, except years, percentages, conversion rate, and Carrying value, long-term $ — $ — $ — $ 419,561 $ 387,338 $ — Carrying value, current portion 435,493 402,320 520,313 — — 516,586 Unamortized discount 14,507 47,680 179,622 30,439 62,662 183,349 Principal amount $ 450,000 $ 450,000 $ 699,935 $ 450,000 $ 450,000 $ 699,935 Carrying amount of permanent equity component, net of tax $ 61,723 $ 57,215 $ 148,487 $ 76,230 $ 104,895 $ 144,760 Carrying amount of temporary equity component, net of tax $ 14,507 $ 47,679 $ 179,622 $ — $ — $ 183,349 Remaining amortization period (years) 0.9 2.9 25.9 Effective interest rate on liability component 4.29% 5.27% 4.28% Fair Value of Notes (Level 2) $ 604,004 $ 643,500 $ 1,679,844 Conversion rate (shares of common stock per $1,000 principal amount of notes) 16.0806 16.0806 28.8585 Conversion price (per share of common stock) $ 62.19 $ 62.19 $ 34.65 If-converted value in excess of par value $ 149,598 $ 149,598 $ 973,758 |
Warrants and Convertible Note Hedge Arrangements | The following table presents the details of the warrants and convertible note hedge arrangements as of June 28, 2015: 2016 Notes 2018 Notes (shares in thousands) Warrants: Number of shares to be delivered upon exercise 7,236 7,236 Exercise price $70.40 $75.10 Expiration date range August 15 - October 21, 2016 August 15 - October 23, 2018 Convertible Note Hedge: Number of shares available from counterparties 7,236 7,236 Exercise price $62.19 $62.19 |
Components of Senior Notes | As of June 28, 2015 the Senior Notes consisted of the following: June 28, 2015 2020 Notes 2025 Notes (in thousands, except years) Carrying value, long-term $ 497,053 $ 496,907 Unamortized discount 2,947 3,093 Principal amount $ 500,000 $ 500,000 Remaining amortization period (years) 4.7 9.7 Fair Value of Notes (Level 2) $ 497,805 $ 492,945 |
Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes | The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Senior Notes and the Convertible Notes during the twelve months ended June 29, 2015, June 28, 2014, and June 30, 2013. Twelve Months Ended June 28, June 29, June 30, (in thousands) Contractual interest coupon $ 36,074 $ 26,248 $ 26,248 Amortization of interest discount 34,886 33,065 31,560 Amortization of issuance costs 2,435 2,362 2,362 Amortization of interest rate contract 113 — — Total interest cost recognized $ 73,508 $ 61,675 $ 60,170 |
Schedule of Contractual Cash Obligations Relating to Convertible Notes and Other Long-Term Debt | The Company’s contractual cash obligations relating to its Convertible Notes and other long-term debt as of June 28, 2015 were as follows: Long-term (in thousands) Payments due by period: 2016* $ 1,599,935 2017 — 2018 — 2019 — 2020 500,000 Thereafter 500,000 Total 2,599,935 Current portion of long-term debt 1,599,935 Long-term debt $ 1,000,000 * As noted above, the conversion periods for the Convertible Notes are open as of June 28, 2015. As there is the potential for conversion at the option of the holder, the principal balance of the 2018 and 2041 Notes have been included in the one year payment period. As of August 6, 2015, none of the Convertible Notes have been converted during fiscal year 2015 or 2014. |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Contractual Cash Obligations relating to Existing Capital Leases | The Company’s contractual cash obligations relating to its existing capital leases, including interest, as of June 28, 2015 were as follows: Capital (in thousands) Payments due by period: 2016 $ 1,630 2017 7,223 2018 77 2019 77 2020 70 Total 9,077 Interest on capital leases 131 Current portion of capital leases 1,524 Long-term portion of capital leases $ 7,422 |
Schedule of Contractual Cash Obligations Relating to Operating Leases | The Company’s contractual cash obligations with respect to operating leases, excluding the residual value guarantees discussed above, as of June 28, 2015 were as follows: Operating (in thousands) Payments due by period: 2016 $ 17,593 2017 14,004 2018 6,544 2019 5,223 2020 4,847 thereafter 10,811 Less: Sublease Income (478 ) Total $ 58,544 |
Purchase Commitments | The Company’s commitments related to these agreements as of June 28, 2015 were as follows: Purchase (in thousands) Payments due by period: 2016 $ 189,955 2017 980 2018 980 2019 970 2020 970 Total $ 193,855 |
Schedule of Changes in Product Warranty Reserves | Changes in the Company’s product warranty reserves were as follows: Year Ended June 28, June 29, (in thousands) Balance at beginning of period $ 69,385 $ 58,078 Warranties issued during the period 119,119 87,922 Settlements made during the period (100,196 ) (80,280 ) Changes in liability for pre-existing warranties 4,901 3,665 Balance at end of period $ 93,209 $ 69,385 |
Stock Repurchase Program (Table
Stock Repurchase Program (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Schedule of Repurchases under Repurchase Program | Repurchases under the repurchase program were as follows during the periods indicated: Period Total Number Total Average Amount Available (in thousands, except per share data) Available balance as of June 29, 2014 $ 830,895 Quarter ended September 28, 2014 3,818 $ 296,721 $ 70.01 $ 534,174 Quarter ended December 28, 2014 869 $ 45,694 $ 77.31 $ 488,480 Quarter ended March 29, 2015 1,434 $ 112,477 $ 78.45 $ 376,003 Quarter ended June 28, 2015 754 $ 59,416 $ 78.80 $ 316,587 * Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See the section below for discussion regarding average price associated with the transaction. |
Comprehensive Income (Loss) (Ta
Comprehensive Income (Loss) (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Components of Accumulated Other Comprehensive Loss | The components of accumulated other comprehensive loss, net of tax at the end of the period, as well as the activity during the period, were as follows: Accumulated Accumulated Accumulated Accumulated Total (in thousands) Balance as of June 29, 2014 $ (12,986 ) $ (66 ) $ 1,557 $ (17,160 ) $ (28,655 ) Other comprehensive income (loss) before reclassifications (18,438 ) 1,595 (5,389 ) 1,109 (21,123 ) (Gains) losses reclassified from accumulated other comprehensive income (loss) to net income (3,701 ) (4,388 )(1) 71 (2) — (8,018 ) Net current-period other comprehensive income (loss) $ (22,139 ) $ (2,793 ) $ (5,318 ) $ 1,109 $ (29,141 ) Balance as of June 28, 2015 $ (35,125 ) $ (2,859 ) $ (3,761 ) $ (16,051 ) $ (57,796 ) (1) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $10,136 gain, cost of goods sold: $3,704 loss, selling, general and administrative expenses: $1,974 loss, and other income and expense: $70 Loss (2) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net |
Tax Related to Components of Other Comprehensive Income | Tax related to the components of other comprehensive income during the period were as follows: Year Ended June 28, June 29, June 30, (in thousands) Tax benefit (expense) on change in unrealized gains/losses on cash flow hedges: Tax benefit (expense) on unrealized gains/losses arising during the period $ 1,885 $ (1,065 ) $ (1,312 ) Tax (benefit) expense on gains/losses reclassified to earnings (92 ) 1,615 818 1,793 550 (494 ) Tax benefit (expense) on change in unrealized gains/losses on available-for-sale investments: Tax benefit (expense) on unrealized gains/losses arising during the period 1,796 (735 ) 1,428 Tax (benefit) expense on gains/losses reclassified to earnings 31 493 (2,026 ) 1,827 (242 ) (598 ) Tax benefit (expense) on change in unrealized components of defined benefit plans (871 ) 1,895 586 Tax benefit (expense) on other comprehensive income(loss) $ 2,749 $ 2,203 $ (506 ) |
Segment, Geographic Informati42
Segment, Geographic Information and Major Customers (Tables) | 12 Months Ended |
Jun. 28, 2015 | |
Revenues and Long Lived Assets by Geographic Region | Revenues and long-lived assets by geographic region were as follows: Year Ended June 28, June 29, June 30, (in thousands) Revenue: Korea $ 1,406,617 $ 1,127,406 $ 603,821 Taiwan 1,084,239 1,049,214 1,026,548 United States 890,891 622,022 734,324 China 661,094 623,408 319,282 Japan 623,575 634,131 368,095 Europe 314,546 303,730 292,432 Southeast Asia 278,350 247,398 254,414 Total revenue $ 5,259,312 $ 4,607,309 $ 3,598,916 June 28, June 29, June 30, (in thousands) Long-lived assets: United States $ 505,814 $ 429,548 $ 484,273 Europe 86,779 89,221 109,934 Korea 18,230 18,776 991 Taiwan 8,908 4,259 2,953 China 960 846 2,291 Japan 378 454 680 Southeast Asia 349 392 2,788 $ 621,418 $ 543,496 $ 603,910 |
Summary of Significant Accoun43
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Assets [Line Items] | ||||
Impairments of goodwill | $ 79,444,000 | $ 79,444,000 | $ 0 | $ 0 |
Indefinite-lived intangible asset impairment charge | 0 | 4,000,000 | 0 | |
Impairments of long lived assets held for use | $ 9,800,000 | $ 7,600,000 | $ 0 | |
Equipment | Minimum | ||||
Assets [Line Items] | ||||
Property and equipment, useful life | 3 years | |||
Equipment | Maximum | ||||
Assets [Line Items] | ||||
Property and equipment, useful life | 5 years | |||
Furniture and Fixtures | ||||
Assets [Line Items] | ||||
Property and equipment, useful life | 5 years | |||
Computer Software | Minimum | ||||
Assets [Line Items] | ||||
Property and equipment, useful life | 3 years | |||
Computer Software | Maximum | ||||
Assets [Line Items] | ||||
Property and equipment, useful life | 5 years | |||
Building | ||||
Assets [Line Items] | ||||
Property and equipment, useful life | 25 years |
Equity Based Compensation Plans
Equity Based Compensation Plans - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options and restricted stock units vesting period, years | 3 years | ||
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized compensation expense | $ 2.6 | ||
Weighted average remaining period for recognition, years | 2 months | ||
ESPP purchase price per share as percentage of fair market value | 85.00% | ||
Increase in shares available for issuance under ESPP | 0 | 0 | 0 |
Common stock issued to employees | 943,055 | ||
Number of shares available for purchase under ESPP | 7,434,523 | ||
Employee Stock Purchase Plan | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Unrecognized compensation expense | $ 2.9 | ||
Weighted average remaining period for recognition, years | 2 years 1 month 6 days | ||
Restricted Stock Units (RSUs) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average remaining period for recognition, years | 2 years 1 month 6 days | ||
Unrecognized compensation expense | $ 197.6 | ||
Market-Based Performance Restricted Stock Units (PRSU) | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options and RSUs issued and outstanding under stock plans | 900,000 | ||
Stock price performance measurement period | 50 days | ||
Percentage increase in market-based PRSUs from target | 2.00% | ||
Percentage increase in common stock price exceeding market price performance | 1.00% | ||
Stock compensation expense | $ 13.5 | $ 3.8 | |
Market-Based Performance Restricted Stock Units (PRSU) | Minimum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Common stock to be issued, vesting percentage | 0.00% | ||
Market-Based Performance Restricted Stock Units (PRSU) | Maximum | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Common stock to be issued, vesting percentage | 150.00% | ||
Existing Stock Plans | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options and RSUs issued and outstanding under stock plans | 5,789,920 | ||
Shares available for future issuance under stock plan | 6,572,350 | ||
Novellus Systems Incorporated | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options and restricted stock units vesting period, years | 4 years |
Recognized Equity Based Compens
Recognized Equity Based Compensation Expenses and Related Income Tax Benefit (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Equity-based compensation expense | $ 135,354 | $ 103,700 | $ 99,330 |
Income tax benefit recognized in the related to equity-based compensation | 23,660 | 16,937 | 17,647 |
Income tax benefit realized from the exercise and vesting of options and RSUs | $ 40,401 | $ 31,993 | $ 21,625 |
Summary of Stock Plan Activity
Summary of Stock Plan Activity (Detail) - $ / shares | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Options Outstanding Number of Shares | |||
Beginning balance | 1,331,886 | 2,570,923 | 3,902,077 |
Granted | 76,659 | 166,455 | 288,867 |
Exercised | (564,558) | (1,403,019) | (1,546,028) |
Canceled | (8,155) | (2,473) | (73,993) |
Ending balance | 835,832 | 1,331,886 | 2,570,923 |
Weighted-Average Exercise Price | |||
Beginning balance | $ 32.20 | $ 26.87 | $ 25.14 |
Granted | 80.60 | 51.76 | 42.59 |
Exercised | 31.05 | 24.75 | 25.47 |
Canceled | 29.32 | 30.21 | 26.24 |
Ending balance | $ 37.44 | $ 32.20 | $ 26.87 |
Restricted stock units outstanding number of shares | |||
Beginning balance | 5,635,469 | 4,841,796 | 4,331,478 |
Granted | 1,804,937 | 2,811,602 | 2,563,670 |
Canceled | (174,879) | (281,476) | (299,079) |
Vested restricted stock | (2,311,439) | (1,736,453) | (1,754,273) |
Ending balance | 4,954,088 | 5,635,469 | 4,841,796 |
Restricted Stock Units Outstanding Number of Shares Weighted-Average FMV at Grant | |||
Beginning balance | $ 45.83 | $ 39.32 | $ 41.01 |
Granted | 79.74 | 53.21 | 38.76 |
Canceled | 50.16 | 41.16 | 39.70 |
Vested restricted stock | 41.17 | 40.39 | 42.52 |
Ending balance | $ 60.13 | $ 45.83 | $ 39.32 |
Outstanding and Exercisable Opt
Outstanding and Exercisable Options by Price Range (Detail) - Jun. 28, 2015 - $ / shares | Total |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit | $ 9.44 |
Range of Exercise Prices, upper limit | $ 51.76 |
Options Outstanding Number of Options Outstanding | 835,832 |
Options Outstanding Weighted- Average Remaining Life (Years) | 4 years 5 months 1 day |
Options Outstanding Weighted- Average Exercise Price | $ 37.44 |
Options Exercisable Number of Options Exercisable | 622,695 |
Options Exercisable Weighted- Average Exercise Price | $ 29.29 |
Range One | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit | 9.44 |
Range of Exercise Prices, upper limit | $ 19.05 |
Options Outstanding Number of Options Outstanding | 130,682 |
Options Outstanding Weighted- Average Remaining Life (Years) | 6 months 7 days |
Options Outstanding Weighted- Average Exercise Price | $ 12.94 |
Options Exercisable Number of Options Exercisable | 130,682 |
Options Exercisable Weighted- Average Exercise Price | $ 12.94 |
Range Two | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit | 21.04 |
Range of Exercise Prices, upper limit | $ 25.60 |
Options Outstanding Number of Options Outstanding | 89,907 |
Options Outstanding Weighted- Average Remaining Life (Years) | 3 months 18 days |
Options Outstanding Weighted- Average Exercise Price | $ 22.13 |
Options Exercisable Number of Options Exercisable | 86,845 |
Options Exercisable Weighted- Average Exercise Price | $ 22.08 |
Range Three | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit | 26.87 |
Range of Exercise Prices, upper limit | $ 29.68 |
Options Outstanding Number of Options Outstanding | 193,978 |
Options Outstanding Weighted- Average Remaining Life (Years) | 10 months 10 days |
Options Outstanding Weighted- Average Exercise Price | $ 29.26 |
Options Exercisable Number of Options Exercisable | 190,025 |
Options Exercisable Weighted- Average Exercise Price | $ 29.32 |
Range Four | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit | 31.45 |
Range of Exercise Prices, upper limit | $ 35.68 |
Options Outstanding Number of Options Outstanding | 30,042 |
Options Outstanding Weighted- Average Remaining Life (Years) | 2 months 16 days |
Options Outstanding Weighted- Average Exercise Price | $ 32.94 |
Options Exercisable Number of Options Exercisable | 30,042 |
Options Exercisable Weighted- Average Exercise Price | $ 32.94 |
Range Five | |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Exercise Prices, lower limit | 42.61 |
Range of Exercise Prices, upper limit | $ 80.60 |
Options Outstanding Number of Options Outstanding | 391,223 |
Options Outstanding Weighted- Average Remaining Life (Years) | 2 years 6 months 11 days |
Options Outstanding Weighted- Average Exercise Price | $ 53.54 |
Options Exercisable Number of Options Exercisable | 185,101 |
Options Exercisable Weighted- Average Exercise Price | $ 43.58 |
Schedule of Stock Options Weigh
Schedule of Stock Options Weighted Average Assumptions (Detail) - Stock Options | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected volatility | 34.45% | 35.28% | 36.60% |
Risk-free interest rate | 1.46% | 1.39% | 0.81% |
Expected term (years) | 4 years 9 months 18 days | 4 years 9 months 11 days | 4 years 9 months 15 days |
Dividend Yield | 0.89% |
Intrinsic of Stock Options (Det
Intrinsic of Stock Options (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Intrinsic value - options outstanding | $ 37,961 | $ 46,283 | $ 44,919 |
Intrinsic value - options exercisable | 33,360 | 31,653 | 36,870 |
Intrinsic value - options exercised | $ 26,806 | $ 41,379 | $ 25,430 |
Schedule of Restricted Stock Un
Schedule of Restricted Stock Units Weighted Average Assumptions (Detail) - Market-Based Performance Restricted Stock Units (PRSU) | 12 Months Ended | |
Jun. 28, 2015 | Jun. 29, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Expected volatility | 27.93% | 29.27% |
Risk-free interest rate | 1.05% | 0.55% |
Expected term (years) | 2 years 11 months 23 days | 2 years 8 months 1 day |
Dividend Yield | 0.89% |
Schedule of ESPP Weighted-Avera
Schedule of ESPP Weighted-Average Assumptions (Detail) - Employee Stock Purchase Plan | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Expected term (years) | 8 months 1 day | 8 months 5 days | 7 months 21 days |
Expected stock price volatility | 27.60% | 30.24% | 32.42% |
Risk-free interest rate | 0.07% | 0.07% | 0.15% |
Dividend Yield | 0.69% |
Components of Other Income (Exp
Components of Other Income (Expense), Net (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Component Of Other Expense Income Nonoperating [Line Items] | |||
Interest income | $ 19,268 | $ 12,540 | $ 14,737 |
Interest expense | (73,682) | (61,692) | (60,408) |
Gains on deferred compensation plan related assets, net | 9,071 | 9,559 | 9,764 |
Foreign exchange gains (losses) | 2,331 | 1,529 | (6,808) |
Other, net | (4,177) | 668 | (8,698) |
Other income (expense), net | $ (47,189) | $ (37,396) | $ (51,413) |
Income Loss Before Income Taxes
Income Loss Before Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Schedule of Income Before Income Tax [Line Items] | |||
United States | $ 72,728 | $ 78,076 | $ (46,392) |
Foreign | 668,122 | 645,287 | 113,050 |
Income before income taxes | $ 740,850 | $ 723,363 | $ 66,658 |
Provision Benefit for Income ta
Provision Benefit for Income taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Income Taxes [Line Items] | |||
Current | $ 16,795 | $ 31,762 | $ (1,096) |
Deferred | 12,115 | 10,692 | (60,172) |
Federal Income Tax Expense (Benefit), Continuing Operations, Total | 28,910 | 42,454 | (61,268) |
Current | 1,376 | 3,192 | 3,332 |
Deferred | 158 | (869) | (6,351) |
State and Local Income Tax Expense (Benefit), Continuing Operations, Total | 1,534 | 2,323 | (3,019) |
Current | 61,551 | 49,273 | 20,640 |
Deferred | (6,722) | (2,976) | (3,574) |
Foreign Income Tax Expense (Benefit), Continuing Operations, Total | 54,829 | 46,297 | 17,066 |
Total Provision (Benefit) for Income Taxes | $ 85,273 | $ 91,074 | $ (47,221) |
Components of Net Defered Tax A
Components of Net Defered Tax Assets (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Deferred tax assets: | ||
Tax carryforwards | $ 129,234 | $ 170,028 |
Allowances and reserves | 131,079 | 126,895 |
Equity-based compensation | 21,086 | 18,019 |
Inventory valuation differences | 15,167 | 16,257 |
Other | 13,942 | 12,661 |
Gross deferred tax assets | 310,508 | 343,860 |
Valuation allowance | (85,620) | (74,439) |
Net deferred tax assets | 224,888 | 269,421 |
Deferred tax liabilities: | ||
Intangible Assets | (64,725) | (87,329) |
Amortization of goodwill | (12,502) | (11,409) |
Unremitted earnings of foreign subsidiaries | (66,412) | (40,286) |
Other | (6,100) | (5,673) |
Deferred tax liabilities | (318,365) | (294,159) |
Net deferred tax liabilities | (93,477) | (24,738) |
Convertible Debt | ||
Deferred tax liabilities: | ||
Deferred tax liabilities | (130,991) | (117,112) |
Temporary differences for capital assets | ||
Deferred tax liabilities: | ||
Deferred tax liabilities | $ (37,635) | $ (32,350) |
Income taxes - Additional Infor
Income taxes - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | Jun. 30, 2012 | |
Income Taxes [Line Items] | ||||
Valuation allowance for deferred tax assets | $ 85,620 | $ 74,439 | ||
Federal and state tax credit carry forward | $ 134,300 | |||
U.S. federal statutory tax rate | 35.00% | 35.00% | 35.00% | |
Decreased income taxes due to tax ruling in Switzerland | $ 4,800 | $ 7,400 | $ 10,800 | |
Benefit of the tax ruling on diluted earnings per share | $ 0.03 | $ 0.04 | $ 0.06 | |
Unremitted earnings of foreign subsidiaries | $ 3,300,000 | |||
Withholding taxes on unremitted foreign earning | 859,000 | |||
Unrecognized tax benefits | 363,552 | $ 352,112 | $ 333,114 | $ 343,837 |
Increase in unrecognized tax benefits | 11,400 | |||
Unrecognized tax benefits that would impact effective tax rate | 276,800 | 269,400 | 257,700 | |
Gross interest and penalties, relating to unrecognized tax benefits accrued | 35,500 | $ 29,500 | $ 25,500 | |
Federal | ||||
Income Taxes [Line Items] | ||||
Net operating loss carry-forwards | $ 126,300 | |||
Net operating loss carry-forwards expiration year | 2,019 | |||
State | ||||
Income Taxes [Line Items] | ||||
Net operating loss carry-forwards | $ 36,700 | |||
Net operating loss carry-forwards expiration year | 2,016 | |||
Federal and state tax credit carry forward | $ 236,400 | |||
Tax Credit Carryforward Expiry Beginning in Fiscal Year 2017 | ||||
Income Taxes [Line Items] | ||||
Federal and state tax credit carry forward | 19,200 | |||
Tax Credit Carryforward Expiry Beginning in Fiscal Year 2030 | ||||
Income Taxes [Line Items] | ||||
Federal and state tax credit carry forward | 113,300 | |||
Tax Credit Carryforwards with Indefinite Carryforward Period | ||||
Income Taxes [Line Items] | ||||
Federal and state tax credit carry forward | 1,800 | |||
Federal | ||||
Income Taxes [Line Items] | ||||
Additional paid-in capital benefit upon recognition of tax carry-forwards | 20,300 | |||
Foreign Tax Authority | ||||
Income Taxes [Line Items] | ||||
Net operating loss carry-forwards | 31,200 | |||
Foreign Tax Authority | Net Operating Loss Carryforwards with Indefinite Carryforward Period | ||||
Income Taxes [Line Items] | ||||
Net operating loss carry-forwards | 10,200 | |||
Foreign Tax Authority | Net Operating Loss Carryforwards Expiring Beginning in Fiscal Year 2015 | ||||
Income Taxes [Line Items] | ||||
Net operating loss carry-forwards | 21,000 | |||
Federal and State | ||||
Income Taxes [Line Items] | ||||
Capital loss carryforwards | $ 12,000 | |||
Capital loss carry-forwards expiration year | 2,020 | |||
California And Foreign | ||||
Income Taxes [Line Items] | ||||
Valuation allowance for deferred tax assets | $ 85,600 |
Reconciliation of Income Tax Ex
Reconciliation of Income Tax Expense Provided at Federal Statutory Rate to Actual Income Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Reconciliation Of Income Taxes [Line Items] | |||
Income tax expense computed at federal statutory rate | $ 259,297 | $ 253,177 | $ 23,332 |
State income taxes, net of federal tax benefit | (8,611) | 1,884 | (13,588) |
Foreign income taxed at different rates | (175,581) | (164,130) | (40,255) |
Tax credits | (24,416) | (15,650) | (42,593) |
State valuation allowance, net of federal tax benefit | 8,594 | (1,707) | 11,538 |
Equity-based compensation | 28,845 | 23,167 | 20,318 |
Other permanent differences and miscellaneous items | (2,855) | (5,667) | (5,973) |
Total Provision (Benefit) for Income Taxes | $ 85,273 | $ 91,074 | $ (47,221) |
Changes in Balance of Gross Unr
Changes in Balance of Gross Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Schedule of Unrecognized Tax Benefits [Line Items] | |||
Beginning balance | $ 352,112 | $ 333,114 | $ 343,837 |
Settlements and effective settlements with tax authorities | (2,108) | (3,422) | |
Lapse of statute of limitations | (9,376) | (16,048) | (51,422) |
Increases in balances related to tax positions taken during prior periods | 3,729 | 6,225 | 11,352 |
Decreases in balances related to tax positions taken during prior periods | (12,615) | (4,182) | (11,281) |
Increases in balances related to tax positions taken during current period | 31,810 | 33,003 | 35,170 |
Tax positions assumed in Novellus transaction | 8,880 | ||
Ending balance | $ 363,552 | $ 352,112 | $ 333,114 |
Schedule of Numerators and Deno
Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items] | |||
Net income | $ 655,577 | $ 632,289 | $ 113,879 |
Basic average shares outstanding | 159,629 | 164,741 | 168,932 |
Employee stock plans | 3,193 | 2,864 | 2,558 |
Convertible notes | 13,530 | 6,898 | 1,940 |
Warrants | 715 | ||
Diluted average shares outstanding | 177,067 | 174,503 | 173,430 |
Net income per share - basic | $ 4.11 | $ 3.84 | $ 0.67 |
Net income per share - diluted | $ 3.70 | $ 3.62 | $ 0.66 |
Schedule of Potentially Dilutiv
Schedule of Potentially Dilutive Securities Excluded from EPS Calculations (Detail) - shares shares in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Number of potential dilutive securities excluded | 330 | 78 | 534 |
Cash, Cash Equivalents, Short-T
Cash, Cash Equivalents, Short-Term Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Financial Instruments [Line Items] | ||
Cost | $ 4,283,009 | $ 3,228,743 |
Unrealized Gain | 4,261 | 6,551 |
Unrealized (Loss) | (6,352) | (1,400) |
Fair Value | 4,280,918 | 3,233,894 |
Cash and Cash Equivalents | 1,501,539 | 1,452,677 |
Short-Term Investments | 2,574,947 | 1,612,967 |
Restricted Cash & Investments | 170,969 | 146,492 |
Other Assets | 33,463 | 21,758 |
Fair Value Level 1 | ||
Financial Instruments [Line Items] | ||
Cost | 1,735,035 | 1,532,030 |
Unrealized Gain | 2,998 | 3,152 |
Unrealized (Loss) | (908) | (27) |
Fair Value | 1,737,125 | 1,535,155 |
Cash and Cash Equivalents | 1,222,613 | 1,168,261 |
Short-Term Investments | 315,291 | 204,549 |
Restricted Cash & Investments | 165,758 | 140,587 |
Other Assets | 33,463 | 21,758 |
Fair Value Level 2 | ||
Financial Instruments [Line Items] | ||
Cost | 2,271,311 | 1,411,682 |
Unrealized Gain | 1,263 | 3,399 |
Unrealized (Loss) | (5,444) | (1,373) |
Fair Value | 2,267,130 | 1,413,708 |
Cash and Cash Equivalents | 7,474 | 5,290 |
Short-Term Investments | 2,259,656 | 1,408,418 |
Fair Value Level 2 | Municipal Notes And Bonds | ||
Financial Instruments [Line Items] | ||
Cost | 659,550 | 334,329 |
Unrealized Gain | 429 | 1,108 |
Unrealized (Loss) | (335) | (4) |
Fair Value | 659,644 | 335,433 |
Cash and Cash Equivalents | 7,474 | 5,290 |
Short-Term Investments | 652,170 | 330,143 |
Fair Value Level 2 | Corporate Notes And Bonds | ||
Financial Instruments [Line Items] | ||
Cost | 1,329,587 | 874,540 |
Unrealized Gain | 685 | 2,034 |
Unrealized (Loss) | (3,797) | (335) |
Fair Value | 1,326,475 | 876,239 |
Short-Term Investments | 1,326,475 | 876,239 |
Cash | ||
Financial Instruments [Line Items] | ||
Cost | 276,663 | 285,031 |
Fair Value | 276,663 | 285,031 |
Cash and Cash Equivalents | 271,452 | 279,126 |
Restricted Cash & Investments | 5,211 | 5,905 |
Time Deposits | Fair Value Level 1 | ||
Financial Instruments [Line Items] | ||
Cost | 177,567 | 132,549 |
Fair Value | 177,567 | 132,549 |
Cash and Cash Equivalents | 44,738 | |
Restricted Cash & Investments | 132,829 | 132,549 |
Money Market Funds | Fair Value Level 1 | ||
Financial Instruments [Line Items] | ||
Cost | 1,177,875 | 1,168,261 |
Fair Value | 1,177,875 | 1,168,261 |
Cash and Cash Equivalents | 1,177,875 | 1,168,261 |
US Treasury and Agencies | Fair Value Level 1 | ||
Financial Instruments [Line Items] | ||
Cost | 349,009 | 212,436 |
Unrealized Gain | 72 | 178 |
Unrealized (Loss) | (861) | (27) |
Fair Value | 348,220 | 212,587 |
Short-Term Investments | 315,291 | 204,549 |
Restricted Cash & Investments | 32,929 | 8,038 |
US Treasury and Agencies | Fair Value Level 2 | ||
Financial Instruments [Line Items] | ||
Cost | 4,007 | |
Unrealized (Loss) | (4) | |
Fair Value | 4,003 | |
Short-Term Investments | 4,003 | |
Mutual Funds | Fair Value Level 1 | ||
Financial Instruments [Line Items] | ||
Cost | 30,584 | 18,784 |
Unrealized Gain | 2,926 | 2,974 |
Unrealized (Loss) | (47) | |
Fair Value | 33,463 | 21,758 |
Other Assets | 33,463 | 21,758 |
Government-Sponsored Enterprises | Fair Value Level 2 | ||
Financial Instruments [Line Items] | ||
Cost | 53,612 | 27,666 |
Unrealized Gain | 2 | 41 |
Unrealized (Loss) | (249) | (15) |
Fair Value | 53,365 | 27,692 |
Short-Term Investments | 53,365 | 27,692 |
Foreign Government Bonds | Fair Value Level 2 | ||
Financial Instruments [Line Items] | ||
Cost | 50,336 | 35,438 |
Unrealized Gain | 31 | 57 |
Unrealized (Loss) | (161) | (28) |
Fair Value | 50,206 | 35,467 |
Short-Term Investments | 50,206 | 35,467 |
Mortgage Backed Securities - Residential | Fair Value Level 2 | ||
Financial Instruments [Line Items] | ||
Cost | 32,231 | 27,067 |
Unrealized Gain | 72 | 59 |
Unrealized (Loss) | (292) | (182) |
Fair Value | 32,011 | 26,944 |
Short-Term Investments | 32,011 | 26,944 |
Mortgage Backed Securities - Commercial | Fair Value Level 2 | ||
Financial Instruments [Line Items] | ||
Cost | 141,988 | 112,642 |
Unrealized Gain | 44 | 100 |
Unrealized (Loss) | (606) | (809) |
Fair Value | 141,426 | 111,933 |
Short-Term Investments | $ 141,426 | $ 111,933 |
Financial Instruments - Additio
Financial Instruments - Additional Information (Detail) - USD ($) | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Financial Instruments [Line Items] | |||
Other than temporary impairment included in net realized gains (losses) | $ 0 | $ 0 | $ 3,700,000 |
Gains realized from sales of investments | 2,800,000 | 1,500,000 | 1,600,000 |
Losses realized from sales of investments | $ (2,100,000) | $ (2,000,000) | $ (1,500,000) |
Investment classified as short term, contractual maturity period | 1 year | ||
Gains (losses) accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings | $ (2,900,000) | ||
Foreign exchange contracts gains (losses) accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings over the next 12 months | 200,000 | ||
Gains (losses) accumulated in other comprehensive income expects to reclassify from other comprehensive income into earnings, interest rate contracts | $ (3,100,000) | ||
Accounts Receivable | Customer 1 | |||
Financial Instruments [Line Items] | |||
Percentage of account receivable by customer | 17.00% | 15.00% | |
Accounts Receivable | Customer 2 | |||
Financial Instruments [Line Items] | |||
Percentage of account receivable by customer | 13.00% | 13.00% | |
Accounts Receivable | Customer 3 | |||
Financial Instruments [Line Items] | |||
Percentage of account receivable by customer | 12.00% | 12.00% | |
Accounts Receivable | Customer 4 | |||
Financial Instruments [Line Items] | |||
Percentage of account receivable by customer | 11.00% | 12.00% | |
Forward-starting interest rate swap agreements | |||
Financial Instruments [Line Items] | |||
Notional value | $ 375,000,000 | ||
Foreign Exchange Forward Contracts | Cash flow hedging | |||
Financial Instruments [Line Items] | |||
Potential effect of rights of set-off under master netting agreements for derivative contracts assets | 1,900,000 | $ 500,000 | |
Potential effect of rights of set-off under master netting agreements for derivative contracts liabilities | 1,900,000 | 500,000 | |
Net derivative asset from master netting agreements | $ 1,500,000 | $ 1,100,000 | |
Maximum | |||
Financial Instruments [Line Items] | |||
Foreign currency forward contract, expiration period | 24 months | ||
Maximum | Majority of Contracts | |||
Financial Instruments [Line Items] | |||
Foreign currency forward contract, expiration period | 12 months |
Schedule of Cash, Cash Equivale
Schedule of Cash, Cash Equivalents, Short-Term Investments and Restricted Cash and Investments Unrealized Loss Positions (Detail) $ in Thousands | Jun. 28, 2015USD ($) |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | $ 1,666,588 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (6,034) |
Unrealized Losses 12 Months or Greater - Fair Value | 38,505 |
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss | (318) |
Total - Fair Value | 1,705,093 |
Total - Gross Unrealized Loss | (6,352) |
Municipal Notes And Bonds | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 272,388 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (335) |
Total - Fair Value | 272,388 |
Total - Gross Unrealized Loss | (335) |
Corporate Notes And Bonds | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 889,064 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (3,750) |
Unrealized Losses 12 Months or Greater - Fair Value | 16,586 |
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss | (47) |
Total - Fair Value | 905,650 |
Total - Gross Unrealized Loss | (3,797) |
US Treasury and Agencies | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 296,237 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (865) |
Total - Fair Value | 296,237 |
Total - Gross Unrealized Loss | (865) |
Retail Funds | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 3,532 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (47) |
Total - Fair Value | 3,532 |
Total - Gross Unrealized Loss | (47) |
Government-Sponsored Enterprises | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 49,184 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (249) |
Total - Fair Value | 49,184 |
Total - Gross Unrealized Loss | (249) |
Foreign Government Bonds | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 34,882 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (161) |
Total - Fair Value | 34,882 |
Total - Gross Unrealized Loss | (161) |
Mortgage Backed Securities - Residential | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 20,913 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (196) |
Unrealized Losses 12 Months or Greater - Fair Value | 2,190 |
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss | (96) |
Total - Fair Value | 23,103 |
Total - Gross Unrealized Loss | (292) |
Mortgage Backed Securities - Commercial | |
Schedule of Available-for-sale Securities [Line Items] | |
Unrealized Losses Less Than 12 Months - Fair Value | 100,388 |
Unrealized Losses Less Than 12 Months - Gross Unrealized Loss | (431) |
Unrealized Losses 12 Months or Greater - Fair Value | 19,729 |
Unrealized Losses 12 Months or Greater - Gross Unrealized Loss | (175) |
Total - Fair Value | 120,117 |
Total - Gross Unrealized Loss | $ (606) |
Schedule of Amortized Cost and
Schedule of Amortized Cost and Fair Value of Cash Equivalents, Short-Term Investments, and Restricted Cash and Investments with Contractual Maturities (Detail) $ in Thousands | Jun. 28, 2015USD ($) |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |
Due in one year or less, cost | $ 1,651,592 |
Due after one year through five years, cost | 1,944,674 |
Due in more than five years, cost | 379,496 |
Cost | 3,975,762 |
Due in one year or less, estimated fair value | 1,651,673 |
Due after one year through five years, estimated fair value | 1,940,529 |
Due in more than five years, estimated fair value | 378,590 |
Estimated fair value due, Total | $ 3,970,792 |
Schedule of Outstanding Foreign
Schedule of Outstanding Foreign Currency Forward Contracts (Detail) | Jun. 28, 2015USD ($) |
Buy Contracts | |
Derivative [Line Items] | |
Derivatives Designated as Hedging Instruments | $ 41,646,000 |
Derivatives Not Designated as Hedging Instruments | 46,233,000 |
Buy Contracts | Euro | |
Derivative [Line Items] | |
Derivatives Designated as Hedging Instruments | 34,377,000 |
Derivatives Not Designated as Hedging Instruments | 4,049,000 |
Buy Contracts | Korea (South), Won | |
Derivative [Line Items] | |
Derivatives Designated as Hedging Instruments | 7,269,000 |
Derivatives Not Designated as Hedging Instruments | 8,945,000 |
Buy Contracts | Taiwan Dollar | |
Derivative [Line Items] | |
Derivatives Not Designated as Hedging Instruments | 33,239,000 |
Sell Contracts | |
Derivative [Line Items] | |
Derivatives Designated as Hedging Instruments | 18,946,000 |
Derivatives Not Designated as Hedging Instruments | 64,432,000 |
Sell Contracts | Japanese Yen | |
Derivative [Line Items] | |
Derivatives Designated as Hedging Instruments | 18,946,000 |
Derivatives Not Designated as Hedging Instruments | 49,924,000 |
Sell Contracts | Swiss Francs | |
Derivative [Line Items] | |
Derivatives Not Designated as Hedging Instruments | 3,346,000 |
Sell Contracts | Taiwan Dollar | |
Derivative [Line Items] | |
Derivatives Not Designated as Hedging Instruments | $ 11,162,000 |
Schedule of Fair Value of Deriv
Schedule of Fair Value of Derivative Instruments (Detail) - Fair Value Level 2 - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Accrued Liabilities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liability Derivatives, Fair Value | $ 1,917 | $ 923 |
Derivatives Designated As Hedging Instruments | Accrued Liabilities | Foreign Exchange Forward Contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liability Derivatives, Fair Value | 957 | 805 |
Derivatives Not Designated as Hedging Instruments | Accrued Liabilities | Foreign Exchange Forward Contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Liability Derivatives, Fair Value | 960 | 118 |
Prepaid Expenses and Other Current Assets | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset Derivatives, Fair Value | 3,396 | 1,592 |
Prepaid Expenses and Other Current Assets | Derivatives Designated As Hedging Instruments | Foreign Exchange Forward Contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset Derivatives, Fair Value | 3,388 | 483 |
Prepaid Expenses and Other Current Assets | Derivatives Not Designated as Hedging Instruments | Foreign Exchange Forward Contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Asset Derivatives, Fair Value | $ 8 | $ 1,109 |
Schedule of Derivative Instrume
Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Jun. 28, 2015 | Jun. 29, 2014 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Gain (Loss) Recognized in AOCI (Effective Portion) | $ (290) | $ 9,069 |
Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | 4,296 | 12,507 |
Gain (Loss) Recognized (Excluded from Effectiveness) | (87) | 202 |
Foreign Exchange Forward Contracts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Gain (Loss) Recognized | 1,784 | 8,205 |
Foreign Exchange Forward Contracts | Located in revenue | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Gain (Loss) Recognized in AOCI (Effective Portion) | 13,678 | 7,939 |
Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | 11,375 | 9,027 |
Gain (Loss) Recognized (Excluded from Effectiveness) | 258 | 277 |
Foreign Exchange Forward Contracts | Cost of Sales | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Gain (Loss) Recognized in AOCI (Effective Portion) | (6,318) | 812 |
Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | (4,349) | 2,393 |
Gain (Loss) Recognized (Excluded from Effectiveness) | (75) | (52) |
Foreign Exchange Forward Contracts | Located in selling, general, and administrative | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Gain (Loss) Recognized in AOCI (Effective Portion) | (2,579) | 318 |
Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | (2,618) | 1,087 |
Gain (Loss) Recognized (Excluded from Effectiveness) | (39) | $ (23) |
Interest Rate contracts | Other Expenses,net | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Gain (Loss) Recognized in AOCI (Effective Portion) | (5,071) | |
Gain (Loss) Reclassified from AOCI into Income (Effective Portion) | (112) | |
Gain (Loss) Recognized (Excluded from Effectiveness) | $ (231) |
Schedule of Inventories (Detail
Schedule of Inventories (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Inventory [Line Items] | ||
Raw materials | $ 566,645 | $ 449,623 |
Work-in-process | 141,264 | 126,564 |
Finished goods | 235,437 | 164,316 |
Total inventories | $ 943,346 | $ 740,503 |
Schedule of Property and Equipm
Schedule of Property and Equipment Net (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 |
Property, Plant and Equipment [Line Items] | |||
Manufacturing, engineering and office equipment | $ 717,788 | $ 612,688 | |
Computer equipment and software | 137,623 | 131,184 | |
Land | 53,391 | 52,784 | |
Buildings | 238,631 | 199,544 | |
Leasehold improvements | 81,899 | 80,569 | |
Furniture and fixtures | 21,629 | 20,026 | |
Property and equipment, gross | 1,250,961 | 1,096,795 | |
Less: accumulated depreciation and amortization | (629,543) | (553,299) | |
Property and equipment, net | $ 621,418 | $ 543,496 | $ 603,910 |
Property and Equipment - Additi
Property and Equipment - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Property, Plant and Equipment [Line Items] | |||
Depreciation expense | $ 120,300 | $ 129,100 | $ 126,500 |
Gain on sale of a separate buildings and land | $ 83,090 | ||
California | |||
Property, Plant and Equipment [Line Items] | |||
Investment to purchase commercial building | $ 12,700 |
Goodwill and Intangible Asset71
Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Goodwill And Intangible Assets [Line Items] | ||||
Goodwill | $ 1,387,509,000 | $ 1,387,509,000 | $ 1,466,225,000 | |
Impairments of goodwill | 79,444,000 | 79,444,000 | 0 | $ 0 |
Tax deductible goodwill | $ 61,100,000 | 61,100,000 | ||
Intangible asset amortization expense | 157,700,000 | 163,200,000 | 177,600,000 | |
Impairment of in process research and development | 0 | 4,000,000 | $ 0 | |
Existing Technology | ||||
Goodwill And Intangible Assets [Line Items] | ||||
Impairment of intangible assets | $ 9,800,000 | |||
In Process Research And Development | ||||
Goodwill And Intangible Assets [Line Items] | ||||
Impairment of in process research and development | $ 4,000,000 |
Schedule of Intangible Assets (
Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Goodwill And Intangible Assets [Line Items] | ||
Gross intangible assets subject to amortization | $ 1,328,876 | $ 1,327,063 |
Total gross intangible assets | 1,337,976 | 1,347,163 |
Accumulated Amortization | (609,836) | (453,085) |
Net intangible assets subject to amortization | 719,040 | 873,978 |
Intangible assets, net | 728,140 | 894,078 |
Intangible assets not subject to amortization | 9,100 | 20,100 |
Customer Relationships | ||
Goodwill And Intangible Assets [Line Items] | ||
Gross intangible assets subject to amortization | 615,490 | 615,618 |
Accumulated Amortization | (234,968) | (169,162) |
Net intangible assets subject to amortization | 380,522 | 446,456 |
Existing Technology | ||
Goodwill And Intangible Assets [Line Items] | ||
Gross intangible assets subject to amortization | 643,919 | 643,922 |
Accumulated Amortization | (313,071) | (224,246) |
Net intangible assets subject to amortization | 330,848 | 419,676 |
Patents | ||
Goodwill And Intangible Assets [Line Items] | ||
Gross intangible assets subject to amortization | 33,553 | 32,253 |
Accumulated Amortization | (26,431) | (24,407) |
Net intangible assets subject to amortization | 7,122 | 7,846 |
Other Intangible Assets | ||
Goodwill And Intangible Assets [Line Items] | ||
Gross intangible assets subject to amortization | 35,914 | 35,270 |
Accumulated Amortization | (35,366) | (35,270) |
Net intangible assets subject to amortization | 548 | |
Development Rights | ||
Goodwill And Intangible Assets [Line Items] | ||
Intangible assets not subject to amortization | $ 9,100 | 9,100 |
In Process Research And Development | ||
Goodwill And Intangible Assets [Line Items] | ||
Intangible assets not subject to amortization | $ 11,000 |
Estimated Future Amortization E
Estimated Future Amortization Expense of Intangible Assets (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Finite-Lived Intangible Assets [Line Items] | ||
2,016 | $ 156,074 | |
2,017 | 154,122 | |
2,018 | 152,918 | |
2,019 | 114,846 | |
2,020 | 49,700 | |
Thereafter | 91,380 | |
Net intangible assets subject to amortization | $ 719,040 | $ 873,978 |
Schedule of Accrued Expenses an
Schedule of Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands | Jun. 28, 2015 | Jun. 29, 2014 |
Schedule of Accrued Liabilities [Line Items] | ||
Accrued compensation | $ 314,516 | $ 311,054 |
Warranty reserves | 93,209 | 68,324 |
Income and other taxes payable | 39,275 | 93,934 |
Dividend payable | 47,659 | 29,240 |
Other | 154,779 | 101,744 |
Accrued expenses and other current liabilities | $ 649,438 | $ 604,296 |
Long Term Debt and Other Borr75
Long Term Debt and Other Borrowings - Additional Information (Detail) | Mar. 12, 2015USD ($) | Jun. 28, 2015USD ($)d | Jun. 29, 2014USD ($) | Mar. 12, 2014USD ($) | Jun. 30, 2012USD ($) | May. 31, 2011USD ($) |
Debt Instrument [Line Items] | ||||||
Percentage of principal amount of debt redeemed | 100.00% | |||||
Senior notes, debt description | The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020 for the 2020 Notes and on or after December 24, 2024 for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes, plus accrued and unpaid interest. | |||||
2.75% Notes due March 15, 2020 | ||||||
Debt Instrument [Line Items] | ||||||
Notes due | $ 500,000,000 | $ 500,000,000 | ||||
Senior Notes Interest rate percentage | 2.75% | |||||
Debt instruments maturity date | Mar. 15, 2020 | |||||
Debt instrument redemption date | Feb. 15, 2020 | |||||
3.80% Notes due March 15, 2025 | ||||||
Debt Instrument [Line Items] | ||||||
Notes due | $ 500,000,000 | $ 500,000,000 | ||||
Senior Notes Interest rate percentage | 3.80% | |||||
Debt instruments maturity date | Mar. 15, 2025 | |||||
Debt instrument redemption date | Dec. 15, 2024 | |||||
Revolving credit facility | ||||||
Debt Instrument [Line Items] | ||||||
Revolving unsecured credit facility | $ 300,000,000 | |||||
Credit Facility Maturity Period | Mar. 12, 2019 | |||||
Additional increase in the facility | 200,000,000 | |||||
Revolving unsecured credit facility maximum borrowing capacity | $ 500,000,000 | |||||
Consolidated debt to liquidity | $ 1,000,000,000 | |||||
Credit facility outstanding amount | $ 0 | |||||
Revolving credit facility | Maximum | ||||||
Debt Instrument [Line Items] | ||||||
Total consolidated indebtedness to capitalization ratio | 50.00% | |||||
Revolving credit facility | Prime Rate | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 0.50% | |||||
Revolving credit facility | Federal Funds Rate | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 0.50% | |||||
Revolving credit facility | One-month LIBOR | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 1.00% | |||||
Revolving credit facility | One-month LIBOR | Minimum | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 0.00% | |||||
Revolving credit facility | One-month LIBOR | Maximum | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 0.50% | |||||
Revolving credit facility | London Interbank Offered Rate (LIBOR) | Minimum | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 0.90% | |||||
Revolving credit facility | London Interbank Offered Rate (LIBOR) | Maximum | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument basis spread on variable rate | 1.50% | |||||
0.50% Notes due 2016 | ||||||
Debt Instrument [Line Items] | ||||||
Notes due | $ 450,000,000 | $ 450,000,000 | $ 450,000,000 | |||
Senior Notes Interest rate percentage | 0.50% | |||||
Debt instruments maturity date | 2,016 | |||||
1.25% Notes due 2018 | ||||||
Debt Instrument [Line Items] | ||||||
Notes due | $ 450,000,000 | 450,000,000 | $ 450,000,000 | |||
Senior Notes Interest rate percentage | 1.25% | |||||
Debt instruments maturity date | 2,018 | |||||
2.625% Notes due 2041 | ||||||
Debt Instrument [Line Items] | ||||||
Notes due | $ 699,935,000 | $ 699,935,000 | $ 700,000,000 | |||
Senior Notes Interest rate percentage | 2.625% | |||||
Debt instruments maturity date | 2,041 | |||||
Maximum amount of contingent interest rate | 0.60% | |||||
Stock price percentage of conversion price | 130.00% | |||||
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter | d | 20 |
Components of Convertible Notes
Components of Convertible Notes (Detail) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Jun. 28, 2015USD ($)$ / shares | Jun. 29, 2014USD ($) | Jun. 30, 2012USD ($) | May. 31, 2011USD ($) | |
2.625% Notes due 2041 | ||||
Debt Instrument [Line Items] | ||||
Carrying value, current portion | $ 520,313 | $ 516,586 | ||
Unamortized discount | 179,622 | 183,349 | ||
Principal amount | $ 699,935 | 699,935 | $ 700,000 | |
Remaining amortization period (years) | 25 years 10 months 24 days | |||
Effective interest rate on liability component | 4.28% | |||
Fair Value of Notes (Level 2) | $ 1,679,844 | |||
Conversion rate (shares of common stock per $1,000 principal amount of notes) | 28.8585 | |||
Conversion price (per share of common stock) | $ / shares | $ 34.65 | |||
If-converted value in excess of par value | $ 973,758 | |||
2.625% Notes due 2041 | Permanent Equity | ||||
Debt Instrument [Line Items] | ||||
Carrying amount of equity component, net of tax | 148,487 | 144,760 | ||
2.625% Notes due 2041 | Temporary Equity | ||||
Debt Instrument [Line Items] | ||||
Carrying amount of equity component, net of tax | 179,622 | 183,349 | ||
0.50% Notes due 2016 | ||||
Debt Instrument [Line Items] | ||||
Carrying value, long-term | 419,561 | |||
Carrying value, current portion | 435,493 | |||
Unamortized discount | 14,507 | 30,439 | ||
Principal amount | $ 450,000 | 450,000 | $ 450,000 | |
Remaining amortization period (years) | 10 months 24 days | |||
Effective interest rate on liability component | 4.29% | |||
Fair Value of Notes (Level 2) | $ 604,004 | |||
Conversion rate (shares of common stock per $1,000 principal amount of notes) | 16.0806 | |||
Conversion price (per share of common stock) | $ / shares | $ 62.19 | |||
If-converted value in excess of par value | $ 149,598 | |||
0.50% Notes due 2016 | Permanent Equity | ||||
Debt Instrument [Line Items] | ||||
Carrying amount of equity component, net of tax | 61,723 | 76,230 | ||
0.50% Notes due 2016 | Temporary Equity | ||||
Debt Instrument [Line Items] | ||||
Carrying amount of equity component, net of tax | 14,507 | |||
1.25% Notes due 2018 | ||||
Debt Instrument [Line Items] | ||||
Carrying value, long-term | 387,338 | |||
Carrying value, current portion | 402,320 | |||
Unamortized discount | 47,680 | 62,662 | ||
Principal amount | $ 450,000 | 450,000 | $ 450,000 | |
Remaining amortization period (years) | 2 years 10 months 24 days | |||
Effective interest rate on liability component | 5.27% | |||
Fair Value of Notes (Level 2) | $ 643,500 | |||
Conversion rate (shares of common stock per $1,000 principal amount of notes) | 16.0806 | |||
Conversion price (per share of common stock) | $ / shares | $ 62.19 | |||
If-converted value in excess of par value | $ 149,598 | |||
1.25% Notes due 2018 | Permanent Equity | ||||
Debt Instrument [Line Items] | ||||
Carrying amount of equity component, net of tax | 57,215 | $ 104,895 | ||
1.25% Notes due 2018 | Temporary Equity | ||||
Debt Instrument [Line Items] | ||||
Carrying amount of equity component, net of tax | $ 47,679 |
Components of Convertible Not77
Components of Convertible Notes (Parenthetical) (Detail) - USD ($) | Jun. 28, 2015 | Jun. 29, 2014 |
2.625% Notes due 2041 | ||
Debt Instrument [Line Items] | ||
Principal amount of convertible debt conversion increments | $ 1,000 | $ 1,000 |
0.50% Notes due 2016 | ||
Debt Instrument [Line Items] | ||
Principal amount of convertible debt conversion increments | 1,000 | 1,000 |
1.25% Notes due 2018 | ||
Debt Instrument [Line Items] | ||
Principal amount of convertible debt conversion increments | $ 1,000 | $ 1,000 |
Warrants and Convertible Note H
Warrants and Convertible Note Hedge Arrangements (Detail) - Jun. 28, 2015 - $ / shares shares in Thousands | Total |
0.50% Notes due 2016 | Warrants | |
Class of Warrant or Right [Line Items] | |
Number of shares available from counterparties | 7,236 |
Exercise price | $ 70.40 |
Expiration date range | August 15 - October 21, 2016 |
0.50% Notes due 2016 | Convertible Note Hedge | |
Class of Warrant or Right [Line Items] | |
Number of shares available from counterparties | 7,236 |
Exercise price | $ 62.19 |
1.25% Notes due 2018 | Warrants | |
Class of Warrant or Right [Line Items] | |
Number of shares available from counterparties | 7,236 |
Exercise price | $ 75.10 |
Expiration date range | August 15 - October 23, 2018 |
1.25% Notes due 2018 | Convertible Note Hedge | |
Class of Warrant or Right [Line Items] | |
Number of shares available from counterparties | 7,236 |
Exercise price | $ 62.19 |
Components of Senior Notes (Det
Components of Senior Notes (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Jun. 28, 2015 | Mar. 12, 2015 | |
2.75% Notes due March 15, 2020 | ||
Debt Instrument [Line Items] | ||
Carrying value, long-term | $ 497,053 | |
Unamortized discount | 2,947 | |
Principal amount | $ 500,000 | $ 500,000 |
Remaining amortization period (years) | 4 years 8 months 12 days | |
Fair Value of Notes (Level 2) | $ 497,805 | |
3.80% Notes due March 15, 2025 | ||
Debt Instrument [Line Items] | ||
Carrying value, long-term | 496,907 | |
Unamortized discount | 3,093 | |
Principal amount | $ 500,000 | $ 500,000 |
Remaining amortization period (years) | 9 years 8 months 12 days | |
Fair Value of Notes (Level 2) | $ 492,945 |
Schedule of Recognized Interest
Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes (Detail) - 2016, 2018, 2020, 2025 and 2041 Notes - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Debt Instrument [Line Items] | |||
Contractual interest coupon | $ 36,074 | $ 26,248 | $ 26,248 |
Amortization of interest discount | 34,886 | 33,065 | 31,560 |
Amortization of issuance costs | 2,435 | 2,362 | 2,362 |
Amortization of interest rate contract | 113 | ||
Total interest cost recognized | $ 73,508 | $ 61,675 | $ 60,170 |
Schedule of Contractual Cash Ob
Schedule of Contractual Cash Obligations Relating to Convertible Notes and Other Long Term Debt (Detail) - Contractual Obligations $ in Thousands | Jun. 28, 2015USD ($) | |
Debt and Financial Instruments [Line Items] | ||
2,016 | [1] | $ 1,599,935 |
2,017 | 0 | |
2,018 | 0 | |
2,019 | 0 | |
2,020 | 500,000 | |
Thereafter | 500,000 | |
Total | 2,599,935 | |
Current portion of long-term debt | 1,599,935 | |
Long-term debt | $ 1,000,000 | |
[1] | As noted above, the conversion periods for the Convertible Notes are open as of June 28, 2015. As there is the potential for conversion at the option of the holder, the principal balance of the 2018 and 2041 Notes have been included in the one year payment period. As of August 6, 2015, none of the Convertible Notes have been converted during fiscal year 2015 or 2014. |
Retirement and Deferred Compe82
Retirement and Deferred Compensation Plans - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Employee Benefit Plan [Line Items] | |||
Employee 401K contribution | 1.00% | ||
Employee 401K contribution | 75.00% | ||
Employer contribution matching percentage | 50.00% | ||
Maximum employee contributions matched by the Company | 6.00% | ||
Defined benefit plan, contribution by employer | $ 11.8 | $ 10.2 | $ 8.7 |
Deferred compensation plan maximum distribution period | 20 years | ||
Liabilities of Company to plan participants | $ 113.4 | 93.8 | |
Assets correlated to the deferred compensation obligation | 138.9 | 116.7 | |
Defined benefit obligations | $ 30.2 | $ 29 | |
Minimum | |||
Employee Benefit Plan [Line Items] | |||
Payment of benefits, duration after opening of a deferral subaccount or upon retirement | 3 years |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Commitments and Contingencies [Line Items] | |||
Liabilities related to uncertain tax benefits | $ 202,900 | ||
Rental expense | 15,000 | $ 12,000 | $ 14,000 |
Restricted collateral for leasing arrangements | 170,969 | $ 146,492 | |
Standby Letters of Credit | |||
Commitments and Contingencies [Line Items] | |||
Guarantee Obligation Maximum Exposure | 15,500 | ||
Operating Lease Cash Collateral | |||
Commitments and Contingencies [Line Items] | |||
Restricted collateral for leasing arrangements | 132,500 | ||
Operating Lease Marketable Securities Collateral | |||
Commitments and Contingencies [Line Items] | |||
Restricted collateral for leasing arrangements | 32,900 | ||
Operating Leases | |||
Commitments and Contingencies [Line Items] | |||
Operating Lease residual value of guarantee, maximum | $ 219,000 | ||
Maximum percentage of aggregate investment value guaranteed | 100.00% | ||
Guarantee Obligation Maximum Exposure | $ 249,900 |
Schedule of Contractual Cash 84
Schedule of Contractual Cash Obligations relating to Existing Capital Leases (Detail) $ in Thousands | Jun. 28, 2015USD ($) |
Capital Leased Assets [Line Items] | |
2,016 | $ 1,630 |
2,017 | 7,223 |
2,018 | 77 |
2,019 | 77 |
2,020 | 70 |
Total | 9,077 |
Interest on capital leases | 131 |
Current portion of capital leases | 1,524 |
Long-term portion of capital leases | $ 7,422 |
Schedule of Contractual Cash 85
Schedule of Contractual Cash Obligations Relating to Operating Leases (Detail) $ in Thousands | Jun. 28, 2015USD ($) |
Operating Leased Assets [Line Items] | |
2,016 | $ 17,593 |
2,017 | 14,004 |
2,018 | 6,544 |
2,019 | 5,223 |
2,020 | 4,847 |
thereafter | 10,811 |
Less: Sublease Income | (478) |
Total | $ 58,544 |
Purchase Commitments (Detail)
Purchase Commitments (Detail) $ in Thousands | Jun. 28, 2015USD ($) |
Unrecorded Unconditional Purchase Obligation [Line Items] | |
2,016 | $ 189,955 |
2,017 | 980 |
2,018 | 980 |
2,019 | 970 |
2,020 | 970 |
Total | $ 193,855 |
Schedule of Changes in Product
Schedule of Changes in Product Warranty Reserves (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Jun. 28, 2015 | Jun. 29, 2014 | |
Product Warranty Liability [Line Items] | ||
Balance at beginning of period | $ 69,385 | $ 58,078 |
Warranties issued during the period | 119,119 | 87,922 |
Settlements made during the period | (100,196) | (80,280) |
Changes in liability for pre-existing warranties | 4,901 | 3,665 |
Balance at end of period | $ 93,209 | $ 69,385 |
Stock Repurchase Program - Addi
Stock Repurchase Program - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands | Oct. 09, 2014 | Jun. 28, 2015 | Mar. 29, 2015 | Dec. 28, 2014 | Sep. 28, 2014 | Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | Apr. 29, 2014 | |
Stock Repurchase Program [Line Items] | ||||||||||
Net shares of settlements to cover tax withholding obligations | 761,883 | |||||||||
Amount paid for shares under net share settlements | $ 58,800 | |||||||||
Treasury stock purchases | $ 573,240 | $ 244,859 | $ 955,661 | |||||||
Total number of shares repurchased | 754,000 | 1,434,000 | 869,000 | 3,818,000 | ||||||
Treasury stock purchases, weighted average share price | [1] | $ 78.80 | $ 78.45 | $ 77.31 | $ 70.01 | |||||
Repurchase Of Equity | Maximum | ||||||||||
Stock Repurchase Program [Line Items] | ||||||||||
Authorized repurchase of Company common stock | $ 850,000 | |||||||||
Share Repurchase Program Final Settlement | ||||||||||
Stock Repurchase Program [Line Items] | ||||||||||
Treasury stock purchases | $ 250,000 | |||||||||
Total number of shares repurchased | 300,000 | |||||||||
Treasury stock purchases, weighted average share price | $ 72.90 | |||||||||
Share Repurchase Program Final Settlement | Initial delivery | ||||||||||
Stock Repurchase Program [Line Items] | ||||||||||
Total number of shares repurchased | 3,200,000 | |||||||||
[1] | Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See the section below for discussion regarding average price associated with the transaction. |
Schedule of Repurchases under R
Schedule of Repurchases under Repurchase Program (Detail) - USD ($) $ / shares in Units, shares in Thousands | 3 Months Ended | |||||
Jun. 28, 2015 | Mar. 29, 2015 | Dec. 28, 2014 | Sep. 28, 2014 | Jun. 29, 2014 | ||
Stock Repurchase Program [Line Items] | ||||||
Total number of shares repurchased | 754 | 1,434 | 869 | 3,818 | ||
Total Cost of Repurchase | $ 59,416,000 | $ 112,477,000 | $ 45,694,000 | $ 296,721,000 | ||
Average Price Paid Per Share | [1] | $ 78.80 | $ 78.45 | $ 77.31 | $ 70.01 | |
Amount Available Under Repurchase Program | $ 316,587,000 | $ 376,003,000 | $ 488,480,000 | $ 534,174,000 | $ 830,895,000 | |
[1] | Average price paid per share excludes accelerated share repurchases for which cost was incurred during the September 2014 quarter, but that did not settle until the December 2014 quarter. See the section below for discussion regarding average price associated with the transaction. |
Components of Accumulated Other
Components of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance as of June 29, 2014 | $ (28,655) | |||
Other comprehensive income (loss) before reclassifications | (21,123) | |||
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income | (8,018) | |||
Other comprehensive income (loss), net of tax | (29,141) | $ 38 | $ 5,125 | |
Balance as of June 28, 2015 | (57,796) | (28,655) | ||
Accumulated Foreign Currency Translation Adjustment | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance as of June 29, 2014 | (12,986) | |||
Other comprehensive income (loss) before reclassifications | (18,438) | |||
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income | (3,701) | |||
Other comprehensive income (loss), net of tax | (22,139) | |||
Balance as of June 28, 2015 | (35,125) | (12,986) | ||
Accumulated Unrealized Holding Gains (Losses) on Cash Flow Hedges | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance as of June 29, 2014 | (66) | |||
Other comprehensive income (loss) before reclassifications | 1,595 | |||
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income | [1] | (4,388) | ||
Other comprehensive income (loss), net of tax | (2,793) | |||
Balance as of June 28, 2015 | (2,859) | (66) | ||
Accumulated Unrealized Holding Gains (Losses) on Available-For-Sale Investments | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance as of June 29, 2014 | 1,557 | |||
Other comprehensive income (loss) before reclassifications | (5,389) | |||
(Gains) losses reclassified from accumulated other comprehensive income (loss) to net income | [2] | 71 | ||
Other comprehensive income (loss), net of tax | (5,318) | |||
Balance as of June 28, 2015 | (3,761) | 1,557 | ||
Accumulated Unrealized Components of Defined Benefit Plans | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Balance as of June 29, 2014 | (17,160) | |||
Other comprehensive income (loss) before reclassifications | 1,109 | |||
Other comprehensive income (loss), net of tax | 1,109 | |||
Balance as of June 28, 2015 | $ (16,051) | $ (17,160) | ||
[1] | Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in revenue: $10,136 gain, cost of goods sold: $3,704 loss, selling, general and administrative expenses: $1,974 loss, and other income and expense: $70 Loss | |||
[2] | Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net |
Components of Accumulated Oth91
Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) $ in Thousands | 12 Months Ended |
Jun. 28, 2015USD ($) | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Reclassification from accumulated other comprehensive income | $ 8,018 |
Reclassified to Revenue | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Reclassification from accumulated other comprehensive income | 10,136 |
Reclassified to cost of goods sold | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Reclassification from accumulated other comprehensive income | (3,704) |
Reclassified to selling, general, and administrative | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Reclassification from accumulated other comprehensive income | (1,974) |
Reclassified To Other Expense | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |
Reclassification from accumulated other comprehensive income | $ (70) |
Tax Related to Components of Ot
Tax Related to Components of Other Comprehensive Income (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Tax benefit (expense) on change in unrealized gains/losses on cash flow hedges: | |||
Tax benefit (expense) on unrealized gains/losses arising during the period | $ 1,885 | $ (1,065) | $ (1,312) |
Tax (benefit) expense on gains/losses reclassified to earnings | (92) | 1,615 | 818 |
Tax benefit (expense) on change on cash flow hedges | 1,793 | 550 | (494) |
Tax benefit (expense) on change in unrealized gains/losses on available-for-sale investments: | |||
Tax benefit (expense) on unrealized gains/losses arising during the period | 1,796 | (735) | 1,428 |
Tax (benefit) expense on gains/losses reclassified to earnings | 31 | 493 | (2,026) |
Tax benefit (expense) on change on available-for-sale investments | 1,827 | (242) | (598) |
Tax benefit (expense) on change in unrealized components of defined benefit plans | (871) | 1,895 | 586 |
Tax benefit (expense) on other comprehensive income(loss) | $ 2,749 | $ 2,203 | $ (506) |
Segment, Geographic Informati93
Segment, Geographic Information and Major Customers - Additional Information (Detail) | 12 Months Ended | ||
Jun. 28, 2015LocationSegment | Jun. 29, 2014 | Jun. 30, 2013 | |
Segment Reporting Information [Line Items] | |||
Number of reportable business segment | 1 | ||
Number of geographic regions the company operates | Location | 7 | ||
Revenues | Customer 1 | |||
Segment Reporting Information [Line Items] | |||
Percentage of revenue from major customers | 28.00% | 23.00% | 19.00% |
Revenues | Customer 2 | |||
Segment Reporting Information [Line Items] | |||
Percentage of revenue from major customers | 12.00% | 15.00% | 15.00% |
Revenues | Customer 3 | |||
Segment Reporting Information [Line Items] | |||
Percentage of revenue from major customers | 11.00% | 14.00% | 11.00% |
Revenues and Long Lived Assets
Revenues and Long Lived Assets by Geographic Region (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 28, 2015 | Jun. 29, 2014 | Jun. 30, 2013 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | $ 5,259,312 | $ 4,607,309 | $ 3,598,916 |
Long-lived assets | 621,418 | 543,496 | 603,910 |
United States | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 890,891 | 622,022 | 734,324 |
Long-lived assets | 505,814 | 429,548 | 484,273 |
Europe | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 314,546 | 303,730 | 292,432 |
Long-lived assets | 86,779 | 89,221 | 109,934 |
South Korea | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 1,406,617 | 1,127,406 | 603,821 |
Long-lived assets | 18,230 | 18,776 | 991 |
Taiwan | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 1,084,239 | 1,049,214 | 1,026,548 |
Long-lived assets | 8,908 | 4,259 | 2,953 |
China | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 661,094 | 623,408 | 319,282 |
Long-lived assets | 960 | 846 | 2,291 |
Southeast Asia | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 278,350 | 247,398 | 254,414 |
Long-lived assets | 349 | 392 | 2,788 |
Japan | |||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||
Revenues | 623,575 | 634,131 | 368,095 |
Long-lived assets | $ 378 | $ 454 | $ 680 |